SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'DMS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 11GS_B_EAAB211_1 (GLUTATHIONES-TRANSFERASE) |
2wdu | GLUTATHIONETRANSFERASE SIGMACLASS (Fasciolahepatica) | 4 / 7 | TYR A 10PHE A 11GLY A 15ARG A 16 | DMS A1214 ( 4.3A)GSH A 301 (-4.4A)DMS A1214 (-3.0A)GDS A 300 ( 4.1A) | 0.80A | 11gsB-2wduA:24.4 | 11gsB-2wduA:29.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.02A | 1axwA-4pg6A:undetectable | 1axwA-4pg6A:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 9 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.56A | 1bkfA-4lawA:19.3 | 1bkfA-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 9 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.60A | 1bkfA-4lawA:19.3 | 1bkfA-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BU5_B_RBFB302_1 (PROTEIN (FLAVODOXIN)) |
3x1j | PHOSPHOPANTETHEINEADENYLYLTRANSFERASE (Pseudomonasaeruginosa) | 4 / 8 | THR A 14GLY A 18ASP A 19TYR A 123 | ACO A 201 ( 4.6A)DMS A 208 (-3.5A)NoneDMS A 208 (-4.1A) | 1.01A | 1bu5B-3x1jA:2.8 | 1bu5B-3x1jA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9H_A_RAPA108_1 (FKBP12.6) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 (-4.3A) | 0.50A | 1c9hA-4lawA:18.7 | 1c9hA-4lawA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9H_A_RAPA108_1 (FKBP12.6) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneNoneDMS A 304 (-4.3A) | 0.57A | 1c9hA-4lawA:18.7 | 1c9hA-4lawA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) |
2wdu | GLUTATHIONETRANSFERASE SIGMACLASS (Fasciolahepatica) | 5 / 12 | TYR A 93LEU A 135LEU A 138VAL A 139SER A 142 | DMS A1212 ( 4.7A)NoneNoneNoneNone | 1.04A | 1db1A-2wduA:undetectable | 1db1A-2wduA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 10 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.69A | 1fapA-4lawA:19.4 | 1fapA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)NoneDMS A 304 (-4.3A) | 0.87A | 1fapA-4lawA:19.4 | 1fapA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FIQ_C_SALC1335_1 (XANTHINE OXIDASE) |
2yne | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE (Plasmodiumvivax) | 4 / 8 | LEU A 409VAL A 405LEU A 277ALA A 279 | NoneNoneNoneDMS A 999 ( 4.6A) | 0.92A | 1fiqC-2yneA:0.4 | 1fiqC-2yneA:18.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.55A | 1fkbA-4lawA:19.6 | 1fkbA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122 | NoneNoneNoneNoneDMS A 304 (-3.5A)None | 0.85A | 1fkbA-4lawA:19.6 | 1fkbA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.55A | 1fkbA-4lawA:19.6 | 1fkbA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.78A | 1fkfA-4lawA:19.3 | 1fkfA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.83A | 1fkfA-4lawA:19.3 | 1fkfA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.78A | 1fkjA-4lawA:19.4 | 1fkjA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.83A | 1fkjA-4lawA:19.4 | 1fkjA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.56A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122 | NoneNoneNoneNoneDMS A 304 (-3.5A)None | 0.86A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.57A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FMO_E_ADNE351_1 (CAMP-DEPENDENTPROTEIN KINASE) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 7 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388VAL A 422ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)NoneEE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.76A | 1fmoE-6c0tA:41.6 | 1fmoE-6c0tA:17.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_A_URFA1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
6ek6 | LYSINE-SPECIFICDEMETHYLASE5B,LYSINE-SPECIFICDEMETHYLASE 5B (Homosapiens) | 4 / 6 | ASN A 509ILE A 500SER A 505ASN A 601 | 90V A 804 ( 4.6A)DMS A 805 (-4.9A)None90V A 804 (-3.8A) | 1.05A | 1h7xA-6ek6A:undetectable | 1h7xA-6ek6A:6.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_B_URFB1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
6ek6 | LYSINE-SPECIFICDEMETHYLASE5B,LYSINE-SPECIFICDEMETHYLASE 5B (Homosapiens) | 4 / 6 | ASN A 509ILE A 500SER A 505ASN A 601 | 90V A 804 ( 4.6A)DMS A 805 (-4.9A)None90V A 804 (-3.8A) | 1.05A | 1h7xB-6ek6A:undetectable | 1h7xB-6ek6A:6.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_C_URFC1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
6ek6 | LYSINE-SPECIFICDEMETHYLASE5B,LYSINE-SPECIFICDEMETHYLASE 5B (Homosapiens) | 4 / 6 | ASN A 509ILE A 500SER A 505ASN A 601 | 90V A 804 ( 4.6A)DMS A 805 (-4.9A)None90V A 804 (-3.8A) | 1.06A | 1h7xC-6ek6A:undetectable | 1h7xC-6ek6A:6.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H7X_D_URFD1033_1 (DIHYDROPYRIMIDINEDEHYDROGENASE) |
6ek6 | LYSINE-SPECIFICDEMETHYLASE5B,LYSINE-SPECIFICDEMETHYLASE 5B (Homosapiens) | 4 / 6 | ASN A 509ILE A 500SER A 505ASN A 601 | 90V A 804 ( 4.6A)DMS A 805 (-4.9A)None90V A 804 (-3.8A) | 1.06A | 1h7xD-6ek6A:undetectable | 1h7xD-6ek6A:6.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE9_A_VDXA500_1 (VITAMIN D3 RECEPTOR) |
2wdu | GLUTATHIONETRANSFERASE SIGMACLASS (Fasciolahepatica) | 5 / 12 | TYR A 93LEU A 135LEU A 138VAL A 139SER A 142 | DMS A1212 ( 4.7A)NoneNoneNoneNone | 1.09A | 1ie9A-2wduA:undetectable | 1ie9A-2wduA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IEP_B_STIB202_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | LEU A 366VAL A 374ALA A 388GLU A 409MET A 413GLY A 444 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)NoneNone | 0.72A | 1iepB-6c0tA:17.1 | 1iepB-6c0tA:13.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IG3_A_VIBA502_1 (THIAMINPYROPHOSPHOKINASE) |
4yrp | HISTIDYL-TRNASYNTHETASE (Trypanosomacruzi) | 4 / 8 | LEU A 377SER A 197ASP A 73THR A 78 | NoneDMS A 503 (-3.6A)NoneNone | 1.05A | 1ig3A-4yrpA:undetectable1ig3B-4yrpA:2.2 | 1ig3A-4yrpA:19.471ig3B-4yrpA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2S_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.41A | 1k2sA-3sxfA:undetectable1k2sB-3sxfA:undetectable | 1k2sA-3sxfA:20.381k2sB-3sxfA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2S_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.39A | 1k2sA-3sxfA:undetectable1k2sB-3sxfA:undetectable | 1k2sA-3sxfA:20.381k2sB-3sxfA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2U_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.43A | 1k2uA-3sxfA:undetectable1k2uB-3sxfA:undetectable | 1k2uA-3sxfA:20.381k2uB-3sxfA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1M00_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 1m00A-3sxfA:undetectable1m00B-3sxfA:undetectable | 1m00A-3sxfA:20.381m00B-3sxfA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OHR_A_1UNA201_1 (ASPARTYLPROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 11 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.37A | 1ohrA-4g09A:undetectable | 1ohrA-4g09A:12.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OM5_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 8 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.43A | 1om5A-3sxfA:undetectable1om5B-3sxfA:undetectable | 1om5A-3sxfA:20.571om5B-3sxfA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OPJ_B_STIB4_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | VAL A 374ALA A 388GLU A 409MET A 413VAL A 422GLY A 444 | EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)NoneNoneNone | 0.86A | 1opjB-6c0tA:16.4 | 1opjB-6c0tA:13.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OSV_B_CHCB201_1 (BILE ACID RECEPTOR) |
3edi | TOLLOID-LIKE PROTEIN1 (Homosapiens) | 5 / 12 | LEU A 94MET A 34MET A 29ILE A 19ILE A 77 | NoneDMS A 215 ( 3.9A)NoneNoneNone | 1.29A | 1osvB-3ediA:undetectable | 1osvB-3ediA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6H_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 1p6hA-3sxfA:undetectable1p6hB-3sxfA:undetectable | 1p6hA-3sxfA:20.571p6hB-3sxfA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 1p6kA-3sxfA:undetectable1p6kB-3sxfA:undetectable | 1p6kA-3sxfA:20.451p6kB-3sxfA:20.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 12 | TYR A 57ASP A 68GLY A 82TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.95A | 1pbkA-4lawA:19.2 | 1pbkA-4lawA:33.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68GLY A 84VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.65A | 1pbkA-4lawA:19.2 | 1pbkA-4lawA:33.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57GLY A 84VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.50A | 1pbkA-4lawA:19.2 | 1pbkA-4lawA:33.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_A_ADNA1245_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 9 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.60A | 1pk7A-4mchA:31.6 | 1pk7A-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK7_C_ADNC1247_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 10 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.57A | 1pk7C-4mchA:31.9 | 1pk7C-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_A_2FAA306_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 10 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.53A | 1pk9A-4mchA:31.7 | 1pk9A-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_B_2FAB307_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 9 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.54A | 1pk9B-4mchA:32.0 | 1pk9B-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_C_2FAC308_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.57A | 1pk9C-4mchA:30.9 | 1pk9C-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_A_RABA645_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 10 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.55A | 1pw7A-4mchA:31.6 | 1pw7A-4mchA:26.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_B_RABB646_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 9 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.57A | 1pw7B-4mchA:31.8 | 1pw7B-4mchA:26.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 9 | TYR A 57ASP A 68VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.70A | 1q6iA-4lawA:16.7 | 1q6iA-4lawA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 9 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.63A | 1q6iA-4lawA:16.7 | 1q6iA-4lawA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_B_FK5B401_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.75A | 1q6iB-4lawA:16.4 | 1q6iB-4lawA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R5L_A_VIVA301_0 (PROTEIN(ALPHA-TOCOPHEROLTRANSFER PROTEIN)) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 12 | ILE A 122ILE A 25ILE A 105VAL A 129ILE A 87 | NoneNoneNoneNoneDMS A 304 (-3.8A) | 1.28A | 1r5lA-4lawA:undetectable | 1r5lA-4lawA:23.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SG9_B_SAMB302_1 (HEMK PROTEIN) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 3 / 3 | ASP A 281PHE A 226ASN A 265 | DMS A 521 ( 4.9A)NoneNone | 0.73A | 1sg9B-5sytA:undetectable | 1sg9B-5sytA:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T03_P_TFOP822_1 (POL POLYPROTEINSYNTHETICOLIGONUCLEOTIDEPRIMER) |
3tmc | UNCHARACTERIZEDPROTEIN (Bdellovibriobacteriovorus) | 4 / 7 | MET A 267ASP A 268LYS A 145HIS A 149 | NoneDMS A 312 (-4.0A)NoneDMS A 312 (-4.0A) | 1.00A | 1t03A-3tmcA:undetectable | 1t03A-3tmcA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.76A | 1tcoC-4lawA:19.1 | 1tcoC-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.87A | 1tcoC-4lawA:19.1 | 1tcoC-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TLS_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.07A | 1tlsA-4pg6A:undetectable | 1tlsA-4pg6A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TLS_B_C2FB266_0 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.10A | 1tlsB-4pg6A:undetectable | 1tlsB-4pg6A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TSN_A_C2FA266_0 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.06A | 1tsnA-4pg6A:undetectable | 1tsnA-4pg6A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | ALA A 119LYS A 121GLU A 136LEU A 140LEU A 215HIS A 223 | W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)NoneNoneNone | 0.75A | 1uwhB-5myvA:19.7 | 1uwhB-5myvA:23.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 5 / 12 | VAL A 374ALA A 388GLU A 409CYH A 441LEU A 475 | EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)EE4 A 701 (-4.6A)None | 0.53A | 1uwjA-6c0tA:7.6 | 1uwjA-6c0tA:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_A_CRNA401_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.26A | 1v7zA-5sytA:undetectable | 1v7zA-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_B_CRNB3401_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.26A | 1v7zB-5sytA:undetectable | 1v7zB-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_C_CRNC4401_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.27A | 1v7zC-5sytA:undetectable | 1v7zC-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_D_CRND5401_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.26A | 1v7zD-5sytA:undetectable | 1v7zD-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V7Z_E_CRNE6401_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.26A | 1v7zE-5sytA:undetectable | 1v7zE-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_A_ADNA252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.49A | 1vhwA-4mchA:31.91vhwD-4mchA:31.9 | 1vhwA-4mchA:25.701vhwD-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_B_ADNB252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 9 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.45A | 1vhwB-4mchA:32.01vhwF-4mchA:31.6 | 1vhwB-4mchA:25.701vhwF-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_C_ADNC252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.49A | 1vhwC-4mchA:32.01vhwE-4mchA:31.8 | 1vhwC-4mchA:25.701vhwE-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_D_ADND252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.49A | 1vhwA-4mchA:31.91vhwD-4mchA:31.9 | 1vhwA-4mchA:25.701vhwD-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_E_ADNE252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.50A | 1vhwC-4mchA:32.01vhwE-4mchA:31.8 | 1vhwC-4mchA:25.701vhwE-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VHW_F_ADNF252_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 10 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.46A | 1vhwB-4mchA:32.01vhwF-4mchA:31.6 | 1vhwB-4mchA:25.701vhwF-4mchA:25.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VPO_H_TESH1010_1 (ANTI-TESTOSTERONE(HEAVY CHAIN)ANTI-TESTOSTERONE(LIGHT CHAIN)) |
5kta | FDHC (Acinetobacternosocomialis) | 5 / 12 | TYR A 65ALA A 118GLY A 119LEU A 123PHE A 85 | DMS A 204 (-4.5A)NoneNoneNoneNone | 1.17A | 1vpoH-5ktaA:undetectable1vpoL-5ktaA:undetectable | 1vpoH-5ktaA:20.091vpoL-5ktaA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC3_1 (CES1 PROTEIN) |
3d7r | ESTERASE (Staphylococcusaureus) | 5 / 12 | GLY A 152GLY A 154LEU A 157LEU A 98HIS A 95 | NoneNoneNoneDMS A1417 (-3.9A)None | 1.01A | 1ya4C-3d7rA:15.2 | 1ya4C-3d7rA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.74A | 1yatA-4lawA:20.8 | 1yatA-4lawA:26.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.80A | 1yatA-4lawA:20.8 | 1yatA-4lawA:26.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZLQ_B_EDTB1511_0 (NICKEL-BINDINGPERIPLASMIC PROTEIN) |
5kta | FDHC (Acinetobacternosocomialis) | 4 / 8 | TRP A 50ARG A 28TYR A 65THR A 79 | DMS A 204 (-3.4A)SO4 A 202 (-3.1A)DMS A 204 (-4.5A)None | 1.19A | 1zlqB-5ktaA:undetectable | 1zlqB-5ktaA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZP4_B_C2FB996_0 (5,10-METHYLENETETRAHYDROFOLATE REDUCTASE) |
5aih | LIMONENE-1,2-EPOXIDEHYDROLASE (unidentified) | 5 / 10 | ASP A 82SER A 106THR A 78LEU A 26ARG A 43 | NoneNoneNoneNoneDMS A 202 (-3.8A) | 1.29A | 1zp4B-5aihA:0.0 | 1zp4B-5aihA:18.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 1zzqA-3sxfA:undetectable1zzqB-3sxfA:undetectable | 1zzqA-3sxfA:20.461zzqB-3sxfA:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
6cfp | UBIQUITIN-LIKEPROTEINSMT3,POLYMERASEACIDIC PROTEIN (InfluenzaAvirus;Saccharomycescerevisiae) | 5 / 12 | LEU A 470ASN A 471LEU A 469ALA A 472LEU A 511 | NoneNoneDMS A 802 (-4.0A)NoneNone | 1.38A | 2aa6A-6cfpA:undetectable | 2aa6A-6cfpA:14.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AQU_B_DR7B300_2 (HIV-1 PROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 11 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.47A | 2aquB-4g09A:undetectable | 2aquB-4g09A:12.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXE_A_1FLA2003_1 (SERUM ALBUMIN) |
2ciy | CHLOROPEROXIDASE (Leptoxyphiumfumago) | 5 / 9 | LEU A 97PHE A 103LEU A 91ARG A 50LEU A 53 | HEM A 396 (-4.1A)DMS A3036 (-3.8A)NoneNoneHEM A 396 ( 4.3A) | 1.40A | 2bxeA-2ciyA:undetectable | 2bxeA-2ciyA:19.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXF_B_DZPB2001_1 (SERUM ALBUMIN) |
6ek6 | LYSINE-SPECIFICDEMETHYLASE5B,LYSINE-SPECIFICDEMETHYLASE 5B (Homosapiens) | 5 / 12 | ILE A 500LEU A 561VAL A 522GLU A 531LEU A 530 | DMS A 805 (-4.9A)NoneNoneDMS A 805 ( 4.6A)None | 1.30A | 2bxfB-6ek6A:undetectable | 2bxfB-6ek6A:7.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C49_A_ADNA1301_1 (SUGAR KINASE MJ0406) |
3h0u | PUTATIVE ENOYL-COAHYDRATASE (Streptomycesavermitilis) | 5 / 12 | ALA A 121GLY A 120GLY A 122ALA A 154PHE A 100 | NoneDMS A 1 (-3.3A)NoneNoneNone | 1.09A | 2c49A-3h0uA:undetectable | 2c49A-3h0uA:21.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CIZ_A_ACTA1320_0 (CHLOROPEROXIDASE) |
2ciy | CHLOROPEROXIDASE (Leptoxyphiumfumago) | 6 / 6 | ALA A 71PHE A 103ILE A 179VAL A 182GLU A 183PHE A 186 | HEM A 396 (-3.6A)DMS A3036 (-3.8A)DMS A3036 (-4.8A)MAN A 741 ( 4.3A)CYN A1802 ( 3.6A)HEM A 396 ( 4.0A) | 0.24A | 2cizA-2ciyA:53.5 | 2cizA-2ciyA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CIZ_A_ACTA1321_0 (CHLOROPEROXIDASE) |
2ciy | CHLOROPEROXIDASE (Leptoxyphiumfumago) | 5 / 5 | LEU A 70ASN A 74PHE A 103VAL A 182ALA A 267 | DMS A3036 (-3.9A)DMS A3036 (-3.9A)DMS A3036 (-3.8A)MAN A 741 ( 4.3A)EDO A 802 (-4.1A) | 0.31A | 2cizA-2ciyA:53.5 | 2cizA-2ciyA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.51A | 2dg3A-4lawA:19.3 | 2dg3A-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.55A | 2dg3A-4lawA:19.3 | 2dg3A-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 (-4.3A) | 0.56A | 2dg4A-4lawA:18.7 | 2dg4A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 11 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122 | NoneNoneNoneNoneDMS A 304 (-3.5A)None | 0.84A | 2dg4A-4lawA:18.7 | 2dg4A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TYR A 113PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneDMS A 304 (-4.3A) | 0.57A | 2dg4A-4lawA:18.7 | 2dg4A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 (-4.3A) | 0.52A | 2dg9A-4lawA:19.0 | 2dg9A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 0.92A | 2dg9A-4lawA:19.0 | 2dg9A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneDMS A 304 (-4.3A) | 0.47A | 2dg9A-4lawA:19.0 | 2dg9A-4lawA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.75A | 2fkeA-4lawA:19.3 | 2fkeA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.80A | 2fkeA-4lawA:19.3 | 2fkeA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_A_MIXA539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388ASP A 484LYS A 486ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 ( 4.4A)NoneEE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.55A | 2fumA-6c0tA:20.6 | 2fumA-6c0tA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_B_MIXB1539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388MET A 438LYS A 486ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)EE4 A 701 ( 3.8A)NoneEE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.48A | 2fumB-6c0tA:20.0 | 2fumB-6c0tA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_C_MIXC2539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 7 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388MET A 438ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)EE4 A 701 ( 3.8A)EE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.64A | 2fumC-6c0tA:19.4 | 2fumC-6c0tA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367GLY A 369VAL A 374ALA A 388MET A 438ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-3.4A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)EE4 A 701 ( 3.8A)EE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.71A | 2fumD-6c0tA:24.2 | 2fumD-6c0tA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FUM_D_MIXD3539_1 (PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388MET A 438LYS A 486ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)EE4 A 701 ( 3.8A)NoneEE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.73A | 2fumD-6c0tA:24.2 | 2fumD-6c0tA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 8 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 2g6hA-3sxfA:undetectable2g6hB-3sxfA:undetectable | 2g6hA-3sxfA:20.582g6hB-3sxfA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 2g6mA-3sxfA:undetectable2g6mB-3sxfA:undetectable | 2g6mA-3sxfA:20.582g6mB-3sxfA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 2g6mA-3sxfA:undetectable2g6mB-3sxfA:undetectable | 2g6mA-3sxfA:20.582g6mB-3sxfA:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G70_B_SAMB2002_0 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
3tmc | UNCHARACTERIZEDPROTEIN (Bdellovibriobacteriovorus) | 5 / 12 | LEU A 285ASP A 268VAL A 154HIS A 150ALA A 258 | NoneDMS A 312 (-4.0A)None FE A 310 ( 3.3A)None | 1.31A | 2g70B-3tmcA:undetectable | 2g70B-3tmcA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_F_SC2F1291_1 (FICOLIN-2) |
3utn | THIOSULFATESULFURTRANSFERASETUM1 (Saccharomycescerevisiae) | 4 / 6 | LEU X 85SER X 83ASP X 80ASP X 79 | DMS X 409 (-4.0A)NoneNoneNone | 1.22A | 2j2pE-3utnX:undetectable2j2pF-3utnX:undetectable | 2j2pE-3utnX:19.692j2pF-3utnX:19.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2J5M_A_ACTA1321_0 (CHLOROPEROXIDASE) |
2ciy | CHLOROPEROXIDASE (Leptoxyphiumfumago) | 6 / 6 | LEU A 70ASN A 74PHE A 103ILE A 179VAL A 182ALA A 267 | DMS A3036 (-3.9A)DMS A3036 (-3.9A)DMS A3036 (-3.8A)DMS A3036 (-4.8A)MAN A 741 ( 4.3A)EDO A 802 (-4.1A) | 0.18A | 2j5mA-2ciyA:53.4 | 2j5mA-2ciyA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J7X_A_ESTA1454_1 (ESTROGEN RECEPTORBETA) |
3x1j | PHOSPHOPANTETHEINEADENYLYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 12 | LEU A 5ILE A 13GLY A 18HIS A 17LEU A 20 | NoneNoneDMS A 208 (-3.5A)ACO A 201 (-4.1A)None | 1.18A | 2j7xA-3x1jA:undetectable | 2j7xA-3x1jA:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2L8M_A_CAMA415_0 (CAMPHOR5-MONOOXYGENASE) |
3tmc | UNCHARACTERIZEDPROTEIN (Bdellovibriobacteriovorus) | 5 / 9 | THR A 272VAL A 152THR A 156ILE A 140VAL A 137 | DMS A 312 (-4.3A)NoneNoneNoneNone | 1.20A | 2l8mA-3tmcA:undetectable | 2l8mA-3tmcA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NV4_A_ACTA148_0 (UPF0066 PROTEINAF_0241) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 3 / 3 | VAL A 239GLU A 330GLU A 357 | DMS A 504 ( 4.7A)NoneDMS A 504 ( 3.6A) | 0.80A | 2nv4A-4g09A:undetectable | 2nv4A-4g09A:17.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QBM_A_CAMA517_0 (CYTOCHROME P450-CAM) |
3tmc | UNCHARACTERIZEDPROTEIN (Bdellovibriobacteriovorus) | 4 / 8 | THR A 272VAL A 154THR A 153ILE A 147 | DMS A 312 (-4.3A)NoneDMS A 312 (-2.9A)None | 0.90A | 2qbmA-3tmcA:undetectable | 2qbmA-3tmcA:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QK8_A_MTXA200_1 (DIHYDROFOLATEREDUCTASE) |
6f6s | ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 (Zaireebolavirus) | 5 / 12 | ALA A 82GLU A 178LEU A 122PRO A 123TYR A 232 | GOL A 506 ( 4.7A)GOL A 506 (-4.0A)NoneDMS A 512 ( 4.5A)None | 1.20A | 2qk8A-6f6sA:undetectable | 2qk8A-6f6sA:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VCD_A_RAPA138_1 (OUTER MEMBRANEPROTEIN MIP) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57PHE A 67ASP A 68VAL A 86ILE A 87TRP A 90TYR A 113 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)None | 0.80A | 2vcdA-4lawA:14.0 | 2vcdA-4lawA:23.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VCD_A_RAPA138_1 (OUTER MEMBRANEPROTEIN MIP) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 11 | TYR A 57PHE A 67PHE A 77TRP A 90TYR A 113 | NoneNoneNoneDMS A 304 ( 4.0A)None | 1.29A | 2vcdA-4lawA:14.0 | 2vcdA-4lawA:23.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57PHE A 67ARG A 73PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.87A | 2vn1A-4lawA:21.0 | 2vn1A-4lawA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57PHE A 67ASP A 68ARG A 73PHE A 77VAL A 86TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.92A | 2vn1A-4lawA:21.0 | 2vn1A-4lawA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.74A | 2vn1B-4lawA:20.9 | 2vn1B-4lawA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.75A | 2vn1B-4lawA:20.9 | 2vn1B-4lawA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VUF_A_FUAA2002_1 (SERUM ALBUMIN) |
3i1a | SPECTINOMYCINPHOSPHOTRANSFERASE (Legionellapneumophila) | 4 / 9 | ARG A 187PHE A 317VAL A 323GLU A 324 | DMS A 341 (-4.4A)NoneNoneNone | 0.86A | 2vufA-3i1aA:2.3 | 2vufA-3i1aA:19.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WB9_A_CYSA301_0 (GLUTATHIONETRANSFERASE SIGMACLASS) |
2wdu | GLUTATHIONETRANSFERASE SIGMACLASS (Fasciolahepatica) | 5 / 5 | TYR A 10GLY A 15ARG A 16TYR A 106TYR A 110 | DMS A1214 ( 4.3A)DMS A1214 (-3.0A)GDS A 300 ( 4.1A)NoneGDS A 300 (-4.6A) | 0.17A | 2wb9A-2wduA:36.4 | 2wb9A-2wduA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WEK_A_DIFA1376_1 (ZINC-BINDING ALCOHOLDEHYDROGENASEDOMAIN-CONTAININGPROTEIN 2) |
4y99 | TROPONIN I, CARDIACMUSCLETROPONIN T, CARDIACMUSCLE (Homosapiens) | 4 / 8 | LEU C 93LEU B 229LYS B 232ALA B 233 | NoneNoneDMS B 301 (-2.7A)None | 1.05A | 2wekA-4y99C:undetectable | 2wekA-4y99C:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y05_A_RALA802_1 (PROSTAGLANDINREDUCTASE 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 4 / 7 | ARG A 157GLY A 139VAL A 53ASP A 141 | DMS A 302 (-4.0A)NoneNoneNone | 0.80A | 2y05A-4lawA:undetectable2y05B-4lawA:undetectable | 2y05A-4lawA:21.622y05B-4lawA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZVA_A_1N1A513_1 (TYROSINE-PROTEINKINASE LYN) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 8 / 12 | LEU A 98ALA A 119LYS A 121GLU A 136VAL A 157GLY A 181LEU A 232ALA A 540 | W4A A 716 (-4.1A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)DMS A 717 (-4.3A)W4A A 716 (-3.8A)NoneDMS A 717 ( 4.5A) | 1.03A | 2zvaA-5myvA:22.5 | 2zvaA-5myvA:24.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A25_A_SAMA279_1 (UNCHARACTERIZEDPROTEIN PH0793) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 3 / 3 | MET A 180GLU A 163ASP A 161 | DMS A 513 ( 4.3A)NoneNone | 1.10A | 3a25A-4mchA:undetectable | 3a25A-4mchA:25.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_A_CRNA303_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.24A | 3a6jA-5sytA:undetectable | 3a6jA-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A6J_C_CRNC305_1 (CREATININEAMIDOHYDROLASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 5 / 8 | GLU A 415HIS A 335HIS A 459HIS A 339GLU A 336 | ZN A 517 (-2.1A) ZN A 517 (-3.2A)DMS A 523 (-4.3A) ZN A 517 (-3.2A) ZN A 517 (-3.9A) | 1.24A | 3a6jC-5sytA:undetectable | 3a6jC-5sytA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3b3mA-3sxfA:undetectable3b3mB-3sxfA:undetectable | 3b3mA-3sxfA:20.773b3mB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3b3mA-3sxfA:undetectable3b3mB-3sxfA:undetectable | 3b3mA-3sxfA:20.773b3mB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3P_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.42A | 3b3pA-3sxfA:undetectable3b3pB-3sxfA:undetectable | 3b3pA-3sxfA:20.773b3pB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BWY_A_SAMA301_0 (COMT PROTEIN) |
5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homosapiens) | 5 / 12 | VAL A 430GLU A 451GLY A 423ILE A 384HIS A 421 | None MN A 601 ( 2.5A)DMS A 607 ( 4.4A)NoneNone | 1.40A | 3bwyA-5x49A:undetectable | 3bwyA-5x49A:19.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D1Y_A_ROCA201_1 (HIV-1 PROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 12 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.44A | 3d1yA-4g09A:undetectable | 3d1yA-4g09A:12.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EBZ_B_017B201_1 (PROTEASE) |
3d7r | ESTERASE (Staphylococcusaureus) | 5 / 11 | LEU A 219ASP A 223ASP A 184ILE A 123ILE A 226 | DMS A1416 ( 4.4A)NoneNoneDMS A1416 (-4.8A)None | 1.14A | 3ebzA-3d7rA:undetectable | 3ebzA-3d7rA:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EKT_D_017D200_2 (PROTEASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | LEU A 176GLY A 92ALA A 91GLY A 101ILE A 104 | NoneDMS A 515 ( 4.1A)NoneNoneNone | 1.15A | 3ektD-4mchA:undetectable | 3ektD-4mchA:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EKY_A_DR7A100_1 (PROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 10 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.48A | 3ekyA-4g09A:undetectable | 3ekyA-4g09A:12.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EL1_A_DR7A100_2 (PROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 12 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.39A | 3el1B-4g09A:undetectable | 3el1B-4g09A:12.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ETE_A_H3PA552_1 (GLUTAMATEDEHYDROGENASE) |
3edi | TOLLOID-LIKE PROTEIN1 (Homosapiens) | 4 / 6 | ILE A 77TYR A 17MET A 29HIS A 92 | NoneDMS A 215 (-4.3A)None ZN A 210 (-3.2A) | 1.07A | 3eteA-3ediA:undetectable3eteE-3ediA:undetectable | 3eteA-3ediA:18.843eteE-3ediA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ETE_C_H3PC554_1 (GLUTAMATEDEHYDROGENASE) |
3edi | TOLLOID-LIKE PROTEIN1 (Homosapiens) | 4 / 5 | ILE A 77TYR A 17MET A 29HIS A 92 | NoneDMS A 215 (-4.3A)None ZN A 210 (-3.2A) | 1.08A | 3eteB-3ediA:undetectable3eteC-3ediA:undetectable | 3eteB-3ediA:18.843eteC-3ediA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ETE_F_H3PF552_1 (GLUTAMATEDEHYDROGENASE) |
3edi | TOLLOID-LIKE PROTEIN1 (Homosapiens) | 4 / 7 | MET A 29HIS A 92ILE A 77TYR A 17 | None ZN A 210 (-3.2A)NoneDMS A 215 (-4.3A) | 1.06A | 3eteD-3ediA:undetectable3eteF-3ediA:undetectable | 3eteD-3ediA:18.843eteF-3ediA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EYG_A_MI1A1_1 (TYROSINE-PROTEINKINASE) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388LYS A 390MET A 438ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)EE4 A 701 ( 3.8A)EE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.53A | 3eygA-6c0tA:18.9 | 3eygA-6c0tA:16.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUP_B_MI1B1_1 (TYROSINE-PROTEINKINASE JAK2) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367GLY A 369VAL A 374ALA A 388VAL A 422MET A 438ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-3.4A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)NoneEE4 A 701 ( 3.8A)DMS A 702 ( 3.1A) | 0.77A | 3fupB-6c0tA:25.5 | 3fupB-6c0tA:16.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUP_B_MI1B1_1 (TYROSINE-PROTEINKINASE JAK2) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388LYS A 390VAL A 422MET A 438ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)NoneEE4 A 701 ( 3.8A)DMS A 702 ( 3.1A) | 0.67A | 3fupB-6c0tA:25.5 | 3fupB-6c0tA:16.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G5D_B_1N1B1_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 9 / 12 | LEU A 98VAL A 106ALA A 119LYS A 121GLU A 136VAL A 157GLY A 181LEU A 232ALA A 540 | W4A A 716 (-4.1A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)DMS A 717 (-4.3A)W4A A 716 (-3.8A)NoneDMS A 717 ( 4.5A) | 1.10A | 3g5dB-5myvA:21.4 | 3g5dB-5myvA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GP0_A_NILA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 11) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | VAL A 106ALA A 119GLU A 136LEU A 139LEU A 140HIS A 223 | W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 (-4.0A)NoneNoneNone | 0.99A | 3gp0A-5myvA:20.9 | 3gp0A-5myvA:26.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HGI_A_BEZA284_0 (CATECHOL1,2-DIOXYGENASE) |
5dlk | TQAA (Penicilliumaethiopicum) | 5 / 12 | LEU A 396ILE A 187GLY A 184HIS A 69HIS A 179 | NoneNoneNoneDMS A 507 (-4.5A)DMS A 507 (-4.6A) | 1.31A | 3hgiA-5dlkA:undetectable | 3hgiA-5dlkA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSP_B_H4BB1760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3hspA-3sxfA:undetectable3hspB-3sxfA:undetectable | 3hspA-3sxfA:20.773hspB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3I45_A_NIOA500_1 (TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN) |
4udb | MINERALOCORTICOIDRECEPTOR (Homosapiens) | 4 / 8 | GLU A 868LEU A 924PHE A 859LEU A 862 | DMS A1984 (-3.8A)NoneNoneNone | 0.84A | 3i45A-4udbA:undetectable | 3i45A-4udbA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.70A | 3ihzA-4lawA:20.8 | 3ihzA-4lawA:23.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.77A | 3ihzA-4lawA:20.8 | 3ihzA-4lawA:23.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IHZ_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 8 | TYR A 57ASP A 68PHE A 77TRP A 90TYR A 113ILE A 122 | NoneNoneNoneDMS A 304 ( 4.0A)NoneNone | 0.46A | 3ihzB-4lawA:21.1 | 3ihzB-4lawA:23.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK3_A_0LIA1_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | GLU A 136VAL A 157HIS A 223LEU A 232ALA A 540 | DMS A 717 (-4.0A)DMS A 717 (-4.3A)NoneNoneDMS A 717 ( 4.5A) | 0.55A | 3ik3A-5myvA:19.9 | 3ik3A-5myvA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK3_B_0LIB2_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | ALA A 119GLU A 136VAL A 157HIS A 223ALA A 540 | W4A A 716 ( 3.9A)DMS A 717 (-4.0A)DMS A 717 (-4.3A)NoneDMS A 717 ( 4.5A) | 0.67A | 3ik3B-5myvA:19.8 | 3ik3B-5myvA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK3_B_0LIB2_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | GLU A 136VAL A 157HIS A 223LEU A 232ALA A 540 | DMS A 717 (-4.0A)DMS A 717 (-4.3A)NoneNoneDMS A 717 ( 4.5A) | 0.53A | 3ik3B-5myvA:19.8 | 3ik3B-5myvA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 3jt3A-3sxfA:undetectable3jt3B-3sxfA:undetectable | 3jt3A-3sxfA:20.773jt3B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.48A | 3jt4A-3sxfA:undetectable3jt4B-3sxfA:undetectable | 3jt4A-3sxfA:20.773jt4B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3jt4A-3sxfA:undetectable3jt4B-3sxfA:undetectable | 3jt4A-3sxfA:20.773jt4B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3jt6A-3sxfA:undetectable3jt6B-3sxfA:undetectable | 3jt6A-3sxfA:20.773jt6B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3jwvA-3sxfA:undetectable3jwvB-3sxfA:undetectable | 3jwvA-3sxfA:20.773jwvB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX0_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 3jx0A-3sxfA:undetectable3jx0B-3sxfA:undetectable | 3jx0A-3sxfA:20.653jx0B-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX0_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3jx0A-3sxfA:undetectable3jx0B-3sxfA:undetectable | 3jx0A-3sxfA:20.653jx0B-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX1_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.48A | 3jx1A-3sxfA:undetectable3jx1B-3sxfA:undetectable | 3jx1A-3sxfA:20.653jx1B-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 3jx4A-3sxfA:undetectable3jx4B-3sxfA:undetectable | 3jx4A-3sxfA:20.653jx4B-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_A_TFPA202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 12 | LEU A 126PHE A 122LEU A 56ASP A 57SER A 40 | NoneNoneNoneNoneDMS A1314 ( 3.7A) | 1.20A | 3ko0A-5advA:undetectable3ko0B-5advA:undetectable3ko0C-5advA:undetectable3ko0D-5advA:undetectable | 3ko0A-5advA:15.553ko0B-5advA:15.553ko0C-5advA:15.553ko0D-5advA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_I_TFPI202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 12 | SER A 40LEU A 126PHE A 122LEU A 56ASP A 57 | DMS A1314 ( 3.7A)NoneNoneNoneNone | 1.26A | 3ko0G-5advA:undetectable3ko0H-5advA:undetectable3ko0I-5advA:undetectable3ko0J-5advA:undetectable | 3ko0G-5advA:15.553ko0H-5advA:15.553ko0I-5advA:15.553ko0J-5advA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_J_TFPJ202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 11 | SER A 40LEU A 56ASP A 57LEU A 126PHE A 122 | DMS A1314 ( 3.7A)NoneNoneNoneNone | 1.19A | 3ko0A-5advA:undetectable3ko0B-5advA:undetectable3ko0I-5advA:undetectable3ko0J-5advA:undetectable | 3ko0A-5advA:15.553ko0B-5advA:15.553ko0I-5advA:15.553ko0J-5advA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_L_TFPL202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 12 | LEU A 56ASP A 57LEU A 126PHE A 122SER A 40 | NoneNoneNoneNoneDMS A1314 ( 3.7A) | 1.22A | 3ko0K-5advA:undetectable3ko0L-5advA:undetectable3ko0M-5advA:undetectable3ko0N-5advA:undetectable | 3ko0K-5advA:15.553ko0L-5advA:15.553ko0M-5advA:15.553ko0N-5advA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_M_TFPM202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 12 | LEU A 126PHE A 122LEU A 56ASP A 57SER A 40 | NoneNoneNoneNoneDMS A1314 ( 3.7A) | 1.15A | 3ko0M-5advA:undetectable3ko0N-5advA:undetectable3ko0O-5advA:undetectable3ko0P-5advA:undetectable | 3ko0M-5advA:15.553ko0N-5advA:15.553ko0O-5advA:15.553ko0P-5advA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_P_TFPP202_1 (PROTEIN S100-A4) |
5adv | ENTEROCHELIN UPTAKEPERIPLASMIC BINDINGPROTEIN (Campylobacterjejuni) | 5 / 12 | SER A 40LEU A 56ASP A 57LEU A 126PHE A 122 | DMS A1314 ( 3.7A)NoneNoneNoneNone | 1.19A | 3ko0M-5advA:undetectable3ko0N-5advA:undetectable3ko0O-5advA:undetectable3ko0P-5advA:undetectable | 3ko0M-5advA:15.553ko0N-5advA:15.553ko0O-5advA:15.553ko0P-5advA:15.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 10 | TYR A 57ASP A 68VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.66A | 3kz7A-4lawA:19.4 | 3kz7A-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 10 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 3kz7A-4lawA:19.4 | 3kz7A-4lawA:32.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXK_A_MI1A1125_1 (TYROSINE-PROTEINKINASE JAK3) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367VAL A 374ALA A 388LYS A 390VAL A 422MET A 438ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)NoneEE4 A 701 ( 3.8A)DMS A 702 ( 3.1A) | 0.70A | 3lxkA-6c0tA:24.8 | 3lxkA-6c0tA:13.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR) |
2wdu | GLUTATHIONETRANSFERASE SIGMACLASS (Fasciolahepatica) | 5 / 12 | TYR A 93LEU A 135LEU A 138VAL A 139SER A 142 | DMS A1212 ( 4.7A)NoneNoneNoneNone | 1.31A | 3m7rA-2wduA:undetectable | 3m7rA-2wduA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N5Y_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3n5yA-3sxfA:0.03n5yB-3sxfA:undetectable | 3n5yA-3sxfA:20.773n5yB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N5Z_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 3n5zA-3sxfA:undetectable3n5zB-3sxfA:undetectable | 3n5zA-3sxfA:20.773n5zB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NDX_A_RITA100_2 (PROTEASE) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 11 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.45A | 3ndxB-4g09A:undetectable | 3ndxB-4g09A:12.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLM_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 3nlmA-3sxfA:undetectable3nlmB-3sxfA:undetectable | 3nlmA-3sxfA:20.773nlmB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 3nlmA-3sxfA:undetectable3nlmB-3sxfA:undetectable | 3nlmA-3sxfA:20.773nlmB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 3nloA-3sxfA:undetectable3nloB-3sxfA:undetectable | 3nloA-3sxfA:20.773nloB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3nlvA-3sxfA:undetectable3nlvB-3sxfA:undetectable | 3nlvA-3sxfA:20.773nlvB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLW_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 3nlwA-3sxfA:undetectable3nlwB-3sxfA:undetectable | 3nlwA-3sxfA:20.773nlwB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLX_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3nlxA-3sxfA:undetectable3nlxB-3sxfA:undetectable | 3nlxA-3sxfA:20.773nlxB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLX_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 3nlxA-3sxfA:undetectable3nlxB-3sxfA:undetectable | 3nlxA-3sxfA:20.773nlxB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLZ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.48A | 3nlzA-3sxfA:undetectable3nlzB-3sxfA:undetectable | 3nlzA-3sxfA:20.773nlzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLZ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3nlzA-3sxfA:undetectable3nlzB-3sxfA:undetectable | 3nlzA-3sxfA:20.773nlzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NM0_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3nm0A-3sxfA:undetectable3nm0B-3sxfA:undetectable | 3nm0A-3sxfA:20.773nm0B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NM0_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3nm0A-3sxfA:undetectable3nm0B-3sxfA:undetectable | 3nm0A-3sxfA:20.773nm0B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NNZ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3nnzA-3sxfA:undetectable3nnzB-3sxfA:undetectable | 3nnzA-3sxfA:20.773nnzB-3sxfA:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.68A | 3o5rA-4lawA:22.5 | 3o5rA-4lawA:67.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.79A | 3o5rA-4lawA:22.5 | 3o5rA-4lawA:67.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OEZ_A_STIA601_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
3d7r | ESTERASE (Staphylococcusaureus) | 4 / 5 | VAL A 202ILE A 182MET A 149ARG A 246 | DMS A1402 ( 4.5A)NoneNoneNone | 1.35A | 3oezA-3d7rA:undetectable | 3oezA-3d7rA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNE_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.48A | 3pneA-3sxfA:undetectable3pneB-3sxfA:undetectable | 3pneA-3sxfA:20.773pneB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNE_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3pneA-3sxfA:undetectable3pneB-3sxfA:undetectable | 3pneA-3sxfA:20.773pneB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNF_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 3pnfA-3sxfA:undetectable3pnfB-3sxfA:undetectable | 3pnfA-3sxfA:20.773pnfB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNF_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3pnfA-3sxfA:undetectable3pnfB-3sxfA:undetectable | 3pnfA-3sxfA:20.773pnfB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNG_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3pngA-3sxfA:undetectable3pngB-3sxfA:undetectable | 3pngA-3sxfA:20.773pngB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QLG_A_1N1A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 9 / 12 | LEU A 98VAL A 106ALA A 119LYS A 121GLU A 136VAL A 157GLY A 181LEU A 232ALA A 540 | W4A A 716 (-4.1A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)DMS A 717 (-4.3A)W4A A 716 (-3.8A)NoneDMS A 717 ( 4.5A) | 1.05A | 3qlgA-5myvA:20.8 | 3qlgA-5myvA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RGF_A_BAXA465_1 (CYCLIN-DEPENDENTKINASE 8) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 8 / 12 | VAL A 106ALA A 119GLU A 136LEU A 140PHE A 177LEU A 215HIS A 223ALA A 540 | W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 (-4.0A)NoneDMS A 717 ( 3.9A)NoneNoneDMS A 717 ( 4.5A) | 0.64A | 3rgfA-5myvA:21.1 | 3rgfA-5myvA:26.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQJ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 3rqjA-3sxfA:undetectable3rqjB-3sxfA:undetectable | 3rqjA-3sxfA:20.773rqjB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQJ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3rqjA-3sxfA:undetectable3rqjB-3sxfA:undetectable | 3rqjA-3sxfA:20.773rqjB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQM_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3rqmA-3sxfA:undetectable3rqmB-3sxfA:undetectable | 3rqmA-3sxfA:20.773rqmB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3rqmA-3sxfA:undetectable3rqmB-3sxfA:undetectable | 3rqmA-3sxfA:20.773rqmB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3rqnA-3sxfA:undetectable3rqnB-3sxfA:undetectable | 3rqnA-3sxfA:20.773rqnB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQW_I_ACHI323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
3x1j | PHOSPHOPANTETHEINEADENYLYLTRANSFERASE (Pseudomonasaeruginosa) | 4 / 8 | PHE A 85ILE A 32LEU A 73PHE A 69 | NoneNoneACO A 201 (-3.9A)DMS A 207 (-4.2A) | 1.05A | 3rqwI-3x1jA:undetectable3rqwJ-3x1jA:undetectable | 3rqwI-3x1jA:21.383rqwJ-3x1jA:21.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3Z_A_9PLA501_1 (CYTOCHROME P450 2E1) |
2yne | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE (Plasmodiumvivax) | 4 / 6 | LEU A 392ALA A 279THR A 146LEU A 409 | NoneDMS A 999 ( 4.6A)DMS A 999 ( 4.8A)None | 0.95A | 3t3zA-2yneA:undetectable | 3t3zA-2yneA:22.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3Z_B_9PLB501_1 (CYTOCHROME P450 2E1) |
2yne | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE (Plasmodiumvivax) | 4 / 6 | LEU A 392ALA A 279THR A 146LEU A 409 | NoneDMS A 999 ( 4.6A)DMS A 999 ( 4.8A)None | 0.94A | 3t3zB-2yneA:undetectable | 3t3zB-2yneA:22.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3Z_D_9PLD501_1 (CYTOCHROME P450 2E1) |
2yne | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE (Plasmodiumvivax) | 4 / 6 | LEU A 392ALA A 279THR A 146LEU A 409 | NoneDMS A 999 ( 4.6A)DMS A 999 ( 4.8A)None | 1.00A | 3t3zD-2yneA:undetectable | 3t3zD-2yneA:22.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYL_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 3tylA-3sxfA:undetectable3tylB-3sxfA:undetectable | 3tylA-3sxfA:20.773tylB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 3tyoA-3sxfA:undetectable3tyoB-3sxfA:undetectable | 3tyoA-3sxfA:20.773tyoB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_C_ADNC251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 12 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.63A | 3u40B-4mchA:31.13u40C-4mchA:31.9 | 3u40B-4mchA:26.843u40C-4mchA:26.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_D_ADND251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.60A | 3u40D-4mchA:32.03u40E-4mchA:30.8 | 3u40D-4mchA:26.843u40E-4mchA:26.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3U40_E_ADNE251_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 12 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.66A | 3u40D-4mchA:32.03u40E-4mchA:30.8 | 3u40D-4mchA:26.843u40E-4mchA:26.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U5J_A_08HA1_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 7 / 7 | TRP A 81PRO A 82LEU A 92LEU A 94ASN A 140ILE A 146MET A 149 | NoneV1T A1171 (-4.2A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A)DMS A1169 ( 3.8A) | 0.14A | 3u5jA-4uydA:25.8 | 3u5jA-4uydA:92.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U5K_A_08JA1_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 8 / 8 | TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149 | NoneV1T A1171 (-4.2A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A)DMS A1169 ( 3.8A) | 0.25A | 3u5kA-4uydA:24.5 | 3u5kA-4uydA:92.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U5K_B_08JB2_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 7 / 7 | TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | NoneV1T A1171 (-4.2A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.28A | 3u5kB-4uydA:24.3 | 3u5kB-4uydA:92.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U5K_C_08JC3_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 8 / 8 | TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149 | NoneV1T A1171 (-4.2A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A)DMS A1169 ( 3.8A) | 0.25A | 3u5kC-4uydA:23.7 | 3u5kC-4uydA:92.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U5K_D_08JD4_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 8 / 8 | TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149 | NoneV1T A1171 (-4.2A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A)DMS A1169 ( 3.8A) | 0.36A | 3u5kD-4uydA:23.7 | 3u5kD-4uydA:92.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.71A | 3uf8A-4lawA:19.2 | 3uf8A-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.79A | 3uf8A-4lawA:19.2 | 3uf8A-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFS_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 3ufsA-3sxfA:undetectable3ufsB-3sxfA:undetectable | 3ufsA-3sxfA:20.773ufsB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFS_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 3ufsA-3sxfA:undetectable3ufsB-3sxfA:undetectable | 3ufsA-3sxfA:20.773ufsB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 3ufuA-3sxfA:undetectable3ufuB-3sxfA:undetectable | 3ufuA-3sxfA:20.773ufuB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 3ufvA-3sxfA:undetectable3ufvB-3sxfA:undetectable | 3ufvA-3sxfA:20.773ufvB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UJ7_B_SAMB302_1 (PHOSPHOETHANOLAMINEN-METHYLTRANSFERASE) |
3utn | THIOSULFATESULFURTRANSFERASETUM1 (Saccharomycescerevisiae) | 4 / 5 | SER X 154ASP X 159ASP X 164ILE X 162 | NoneDMS X 405 (-3.1A)NoneNone | 1.32A | 3uj7B-3utnX:undetectable | 3uj7B-3utnX:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNI_B_SALB1345_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
2yne | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE (Plasmodiumvivax) | 4 / 8 | LEU A 409VAL A 405LEU A 277ALA A 279 | NoneNoneNoneDMS A 999 ( 4.6A) | 0.94A | 3uniB-2yneA:undetectable | 3uniB-2yneA:14.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.77A | 3uqaA-4lawA:16.0 | 3uqaA-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.86A | 3uqaA-4lawA:16.0 | 3uqaA-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.56A | 3uqbA-4lawA:19.1 | 3uqbA-4lawA:24.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V5V_A_ACTA511_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
5vcs | ALPHA-1,6-MANNOSYL-GLYCOPROTEIN2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE (Homosapiens) | 4 / 4 | ASN A 126PHE A 155SER A 157GLN A 182 | DMS A 508 ( 4.8A)NoneDMS A 508 (-3.2A)None | 1.29A | 3v5vA-5vcsA:undetectable | 3v5vA-5vcsA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.76A | 3vawA-4lawA:15.7 | 3vawA-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.83A | 3vawA-4lawA:15.7 | 3vawA-4lawA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VQR_A_ACTA1002_0 (PUTATIVEOXIDOREDUCTASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 4 / 6 | GLY A 257VAL A 255ASP A 281THR A 282 | NoneNoneDMS A 521 ( 4.9A)None | 1.20A | 3vqrA-5sytA:undetectable | 3vqrA-5sytA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VQR_B_ACTB1002_0 (PUTATIVEOXIDOREDUCTASE) |
5syt | CAAX PRENYL PROTEASE1 HOMOLOG (Homosapiens) | 4 / 5 | GLY A 257VAL A 255ASP A 281THR A 282 | NoneNoneDMS A 521 ( 4.9A)None | 1.21A | 3vqrB-5sytA:undetectable | 3vqrB-5sytA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 5 / 12 | LEU A 366VAL A 374ALA A 388GLU A 409CYH A 441 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)EE4 A 701 (-4.6A) | 0.55A | 3wzdA-6c0tA:16.3 | 3wzdA-6c0tA:12.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 4 / 5 | LYS A 121VAL A 157LEU A 232ASP A 541 | SO4 A 702 (-3.3A)DMS A 717 (-4.3A)NoneDMS A 717 (-4.3A) | 0.97A | 3wzdA-5myvA:19.6 | 3wzdA-5myvA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 4 / 8 | VAL A 156VAL A 157LEU A 232ILE A 539 | NoneDMS A 717 (-4.3A)NoneNone | 0.54A | 3wzeA-5myvA:19.9 | 3wzeA-5myvA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | ALA A 119LYS A 121GLU A 136LEU A 215HIS A 223LEU A 232ALA A 540 | W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)NoneNoneNoneDMS A 717 ( 4.5A) | 0.79A | 3zosA-5myvA:12.7 | 3zosA-5myvA:24.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | ALA A 119LYS A 121GLU A 136LEU A 215HIS A 223LEU A 232ALA A 540 | W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)NoneNoneNoneDMS A 717 ( 4.5A) | 0.83A | 3zosB-5myvA:12.7 | 3zosB-5myvA:24.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A9J_A_TYLA1188_1 (BROMODOMAINCONTAINING 2) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 5 / 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.38A | 4a9jA-4uydA:20.5 | 4a9jA-4uydA:71.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A9J_B_TYLB1187_1 (BROMODOMAINCONTAINING 2) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 5 / 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.32A | 4a9jB-4uydA:20.8 | 4a9jB-4uydA:71.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A9J_C_TYLC1184_1 (BROMODOMAINCONTAINING 2) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 5 / 5 | VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146 | V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.37A | 4a9jC-4uydA:20.0 | 4a9jC-4uydA:71.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AFG_B_QMRB1214_1 (CAPITELLA TELETAACHBP) |
3tgh | GLIDEOSOME-ASSOCIATED PROTEIN 50 (Plasmodiumfalciparum) | 5 / 9 | ILE A 145ILE A 61PHE A 49TYR A 88TYR A 84 | NoneNoneNoneNoneDMS A 366 ( 4.4A) | 1.19A | 4afgA-3tghA:undetectable4afgE-3tghA:undetectable | 4afgA-3tghA:20.814afgE-3tghA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AFG_E_QMRE1214_1 (CAPITELLA TELETAACHBP) |
3tgh | GLIDEOSOME-ASSOCIATED PROTEIN 50 (Plasmodiumfalciparum) | 5 / 9 | TYR A 88TYR A 84ILE A 145ILE A 61PHE A 49 | NoneDMS A 366 ( 4.4A)NoneNoneNone | 1.23A | 4afgB-3tghA:0.04afgC-3tghA:0.0 | 4afgB-3tghA:20.814afgC-3tghA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AG8_A_AXIA2000_1 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 7 / 12 | LEU A 366VAL A 374ALA A 388LYS A 390GLU A 409VAL A 422GLY A 444 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)NoneNone | 0.74A | 4ag8A-6c0tA:21.3 | 4ag8A-6c0tA:12.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AN2_A_EUIA1382_1 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | LEU A 140ASP A 225LYS A 227ASN A 230ASP A 541GLY A 543 | NoneNoneNoneNoneDMS A 717 (-4.3A)None | 1.39A | 4an2A-5myvA:20.2 | 4an2A-5myvA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C39_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4c39A-3sxfA:undetectable4c39B-3sxfA:undetectable | 4c39A-3sxfA:20.774c39B-3sxfA:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4C66_A_H4CA1168_0 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 9 / 9 | TRP A 81PRO A 82GLN A 85VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149 | NoneV1T A1171 (-4.2A)V1T A1171 (-4.6A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A)DMS A1169 ( 3.8A) | 0.35A | 4c66A-4uydA:25.1 | 4c66A-4uydA:92.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | ALA A 119LYS A 121GLU A 136LEU A 140HIS A 223LEU A 232ALA A 540 | W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)NoneNoneNoneDMS A 717 ( 4.5A) | 0.88A | 4c8bA-5myvA:19.9 | 4c8bA-5myvA:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | ALA A 119LYS A 121GLU A 136LEU A 140HIS A 223LEU A 232ALA A 540 | W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)NoneNoneNoneDMS A 717 ( 4.5A) | 0.85A | 4c8bB-5myvA:19.9 | 4c8bB-5myvA:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4caqA-3sxfA:undetectable4caqB-3sxfA:undetectable | 4caqA-3sxfA:20.774caqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4ctpA-3sxfA:undetectable4ctpB-3sxfA:undetectable | 4ctpA-3sxfA:20.774ctpB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTQ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4ctqA-3sxfA:0.04ctqB-3sxfA:undetectable | 4ctqA-3sxfA:20.774ctqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 4ctqA-3sxfA:undetectable4ctqB-3sxfA:undetectable | 4ctqA-3sxfA:20.774ctqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.49A | 4cttA-3sxfA:undetectable4cttB-3sxfA:undetectable | 4cttA-3sxfA:20.774cttB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4cttA-3sxfA:undetectable4cttB-3sxfA:undetectable | 4cttA-3sxfA:20.774cttB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTV_B_H4BB1720_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.47A | 4ctvA-3sxfA:undetectable4ctvB-3sxfA:undetectable | 4ctvA-3sxfA:20.774ctvB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTW_B_H4BB1720_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4ctwA-3sxfA:undetectable4ctwB-3sxfA:undetectable | 4ctwA-3sxfA:20.774ctwB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX5_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4cx5A-3sxfA:undetectable4cx5B-3sxfA:undetectable | 4cx5A-3sxfA:20.774cx5B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4cx6A-3sxfA:undetectable4cx6B-3sxfA:undetectable | 4cx6A-3sxfA:20.774cx6B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CX6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4cx6A-3sxfA:undetectable4cx6B-3sxfA:undetectable | 4cx6A-3sxfA:20.774cx6B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1N_C_H4BC760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4d1nC-3sxfA:undetectable4d1nD-3sxfA:undetectable | 4d1nC-3sxfA:20.194d1nD-3sxfA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D31_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4d31A-3sxfA:undetectable4d31B-3sxfA:undetectable | 4d31A-3sxfA:20.774d31B-3sxfA:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.56A | 4d9hA-4mchA:31.5 | 4d9hA-4mchA:31.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 11 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.55A | 4danA-4mchA:31.3 | 4danA-4mchA:31.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 12 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.45A | 4danA-4mchA:31.34danB-4mchA:31.6 | 4danA-4mchA:31.674danB-4mchA:31.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.72A | 4drhA-4lawA:21.2 | 4drhA-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.50A | 4drhA-4lawA:21.2 | 4drhA-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.65A | 4drhD-4lawA:21.1 | 4drhD-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.44A | 4drhD-4lawA:21.1 | 4drhD-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.65A | 4driA-4lawA:23.5 | 4driA-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.78A | 4driA-4lawA:23.5 | 4driA-4lawA:59.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.62A | 4drjA-4lawA:23.7 | 4drjA-4lawA:87.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.49A | 4drjA-4lawA:23.7 | 4drjA-4lawA:87.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.90A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.68A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.87A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.68A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.83A | 4dz3A-4lawA:19.3 | 4dz3A-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.95A | 4dz3A-4lawA:19.3 | 4dz3A-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.68A | 4dz3A-4lawA:19.3 | 4dz3A-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.52A | 4dz3A-4lawA:19.3 | 4dz3A-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.72A | 4dz3B-4lawA:19.3 | 4dz3B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.85A | 4dz3B-4lawA:19.3 | 4dz3B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.70A | 4dz3B-4lawA:19.3 | 4dz3B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.55A | 4dz3B-4lawA:19.3 | 4dz3B-4lawA:30.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E3H_A_HQEA303_1 (CARBONIC ANHYDRASE 2) |
3utn | THIOSULFATESULFURTRANSFERASETUM1 (Saccharomycescerevisiae) | 5 / 10 | VAL X 27LEU X 93VAL X 95THR X 110VAL X 119 | NoneNoneNoneNoneDMS X 401 (-4.1A) | 0.93A | 4e3hA-3utnX:undetectable | 4e3hA-3utnX:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FOX_A_D16A301_1 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.14A | 4foxA-4pg6A:undetectable | 4foxA-4pg6A:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FOX_C_D16C301_1 (THYMIDYLATE SYNTHASE) |
5nfh | METHIONYL-TRNASYNTHETASE, PUTATIVE (Trypanosomabrucei) | 5 / 11 | HIS A 395SER A 366GLU A 368LEU A 447LEU A 371 | GOL A 804 (-3.7A)NoneNoneDMS A 806 ( 4.6A)None | 1.40A | 4foxC-5nfhA:undetectable | 4foxC-5nfhA:19.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FOX_G_D16G301_1 (THYMIDYLATE SYNTHASE) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 12 | HIS A 59ILE A 67LEU A 90LEU A 8GLY A 10 | NoneNoneNoneNoneDMS A 511 (-3.2A) | 1.11A | 4foxG-4pg6A:undetectable | 4foxG-4pg6A:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4fvwA-3sxfA:undetectable4fvwB-3sxfA:undetectable | 4fvwA-3sxfA:20.774fvwB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 4fvxA-3sxfA:undetectable4fvxB-3sxfA:undetectable | 4fvxA-3sxfA:20.774fvxB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4fvxA-3sxfA:undetectable4fvxB-3sxfA:undetectable | 4fvxA-3sxfA:20.774fvxB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVY_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4fvyA-3sxfA:undetectable4fvyB-3sxfA:undetectable | 4fvyA-3sxfA:20.774fvyB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4fvzA-3sxfA:undetectable4fvzB-3sxfA:undetectable | 4fvzA-3sxfA:20.774fvzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I1N_A_FOLA201_0 (DIHYDROFOLATEREDUCTASE) |
3utn | THIOSULFATESULFURTRANSFERASETUM1 (Saccharomycescerevisiae) | 5 / 11 | ILE X 58ALA X 60LEU X 85PHE X 56LEU X 111 | NoneDMS X 409 (-3.2A)DMS X 409 (-4.0A)NoneNone | 1.25A | 4i1nA-3utnX:undetectable | 4i1nA-3utnX:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IMT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 4imtA-3sxfA:undetectable4imtB-3sxfA:undetectable | 4imtA-3sxfA:20.774imtB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J26_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
3x1j | PHOSPHOPANTETHEINEADENYLYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 12 | LEU A 5ILE A 13GLY A 18HIS A 17LEU A 20 | NoneNoneDMS A 208 (-3.5A)ACO A 201 (-4.1A)None | 1.29A | 4j26A-3x1jA:undetectable | 4j26A-3x1jA:24.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J7X_B_SASB804_1 (SEPIAPTERINREDUCTASE) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | SER A 146CYH A 219TYR A 214GLY A 543LEU A 542 | NoneNoneNoneNoneDMS A 717 (-4.0A) | 1.13A | 4j7xB-5myvA:undetectable | 4j7xB-5myvA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSF_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4jsfA-3sxfA:undetectable4jsfB-3sxfA:undetectable | 4jsfA-3sxfA:20.774jsfB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSG_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4jsgA-3sxfA:undetectable4jsgB-3sxfA:undetectable | 4jsgA-3sxfA:20.774jsgB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSH_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4jshA-3sxfA:undetectable4jshB-3sxfA:undetectable | 4jshA-3sxfA:20.774jshB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSI_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4jsiA-3sxfA:undetectable4jsiB-3sxfA:undetectable | 4jsiA-3sxfA:20.774jsiB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSJ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4jsjA-3sxfA:undetectable4jsjB-3sxfA:undetectable | 4jsjA-3sxfA:20.774jsjB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5D_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4k5dA-3sxfA:undetectable4k5dB-3sxfA:undetectable | 4k5dA-3sxfA:20.774k5dB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5F_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4k5fA-3sxfA:undetectable4k5fB-3sxfA:undetectable | 4k5fA-3sxfA:20.774k5fB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5G_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4k5gA-3sxfA:undetectable4k5gB-3sxfA:undetectable | 4k5gA-3sxfA:20.774k5gB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K5G_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4k5gA-3sxfA:undetectable4k5gB-3sxfA:undetectable | 4k5gA-3sxfA:20.774k5gB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCN_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4kcnA-3sxfA:undetectable4kcnB-3sxfA:undetectable | 4kcnA-3sxfA:20.774kcnB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCN_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4kcnA-3sxfA:undetectable4kcnB-3sxfA:undetectable | 4kcnA-3sxfA:20.774kcnB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KS8_A_B49A701_1 (SERINE/THREONINE-PROTEIN KINASE PAK 6) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 10 | ALA A 119VAL A 157LEU A 180GLY A 181LEU A 232ASP A 541 | W4A A 716 ( 3.9A)DMS A 717 (-4.3A)W4A A 716 (-4.3A)W4A A 716 (-3.8A)NoneDMS A 717 (-4.3A) | 0.99A | 4ks8A-5myvA:23.5 | 4ks8A-5myvA:25.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.63A | 4laxA-4lawA:33.0 | 4laxA-4lawA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.48A | 4laxA-4lawA:33.0 | 4laxA-4lawA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 4luxA-3sxfA:undetectable4luxB-3sxfA:undetectable | 4luxA-3sxfA:20.774luxB-3sxfA:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.65A | 4nnrA-4lawA:15.84nnrB-4lawA:15.8 | 4nnrA-4lawA:32.624nnrB-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.51A | 4nnrA-4lawA:15.84nnrB-4lawA:15.8 | 4nnrA-4lawA:32.624nnrB-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.71A | 4nnrB-4lawA:15.8 | 4nnrB-4lawA:32.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.54A | 4nnrB-4lawA:15.8 | 4nnrB-4lawA:32.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0S_A_ADNA500_1 (AURORA KINASE A) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 7 / 11 | LEU A 366GLY A 367VAL A 374ALA A 388LYS A 390ASN A 489ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)EE4 A 701 ( 4.9A)DMS A 702 ( 3.1A) | 0.73A | 4o0sA-6c0tA:32.9 | 4o0sA-6c0tA:14.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 12 | TYR A 57ASP A 68ILE A 87ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.8A)NoneDMS A 304 (-4.3A) | 0.72A | 4odrA-4lawA:12.54odrB-4lawA:12.6 | 4odrA-4lawA:17.954odrB-4lawA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 12 | TYR A 57ILE A 87TYR A 113ILE A 122PHE A 130 | NoneDMS A 304 (-3.8A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 4odrA-4lawA:12.54odrB-4lawA:12.6 | 4odrA-4lawA:17.954odrB-4lawA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OTI_A_MI1A1001_1 (SERINE/THREONINE-PROTEIN KINASE N1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 9 / 12 | LEU A 366GLY A 367GLY A 369GLY A 372VAL A 374ALA A 388LYS A 390ASP A 502PHE A 649 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-3.4A)EE4 A 701 (-4.1A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 3.1A)None | 0.72A | 4otiA-6c0tA:23.5 | 4otiA-6c0tA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OTI_A_MI1A1001_1 (SERINE/THREONINE-PROTEIN KINASE N1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366GLY A 367GLY A 372VAL A 374ALA A 388LYS A 390VAL A 422PHE A 649 | EE4 A 701 ( 4.6A)EE4 A 701 (-3.9A)EE4 A 701 (-4.1A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)NoneNone | 0.70A | 4otiA-6c0tA:23.5 | 4otiA-6c0tA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PGH_A_SAMA401_0 (CAFFEIC ACIDO-METHYLTRANSFERASE) |
4oal | CYTOKININDEHYDROGENASE 4 (Zeamays) | 5 / 11 | GLY A 146GLY A 147VAL A 153ASP A 143ILE A 236 | FAD A 601 ( 4.2A)NoneNoneDMS A 604 ( 4.5A)FAD A 601 (-3.9A) | 0.96A | 4pghA-4oalA:undetectable | 4pghA-4oalA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR) |
3x1j | PHOSPHOPANTETHEINEADENYLYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 11 | LEU A 5ILE A 13GLY A 18HIS A 17LEU A 20 | NoneNoneDMS A 208 (-3.5A)ACO A 201 (-4.1A)None | 1.10A | 4pxmB-3x1jA:undetectable | 4pxmB-3x1jA:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QRC_A_0LIA802_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 5 / 12 | ALA A 388GLU A 409MET A 413LEU A 475ARG A 483 | EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)NoneNoneTPO A 517 ( 3.0A) | 1.05A | 4qrcA-6c0tA:16.3 | 4qrcA-6c0tA:14.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.52A | 4qt2A-4lawA:21.1 | 4qt2A-4lawA:24.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.48A | 4qt2A-4lawA:21.1 | 4qt2A-4lawA:24.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.64A | 4qt3A-4lawA:19.9 | 4qt3A-4lawA:24.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 4qt3A-4lawA:19.9 | 4qt3A-4lawA:24.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7I_A_STIA1001_1 (MACROPHAGECOLONY-STIMULATINGFACTOR 1 RECEPTOR) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | VAL A 374ALA A 388LYS A 390GLU A 409MET A 413CYH A 441 | EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)NoneEE4 A 701 (-4.6A) | 0.82A | 4r7iA-6c0tA:15.7 | 4r7iA-6c0tA:16.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_F_377F401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
5zzn | - (-) | 4 / 7 | LEU U 27PHE U 35TYR U 21ARG U 97 | NoneNoneNoneDMS U 202 (-3.8A) | 1.18A | 4twdF-5zznU:undetectable4twdJ-5zznU:undetectable | 4twdF-5zznU:undetectable4twdJ-5zznU:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_G_377G401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
5zzn | - (-) | 4 / 6 | TYR U 21ARG U 97LEU U 27PHE U 35 | NoneDMS U 202 (-3.8A)NoneNone | 1.10A | 4twdF-5zznU:undetectable4twdG-5zznU:undetectable | 4twdF-5zznU:undetectable4twdG-5zznU:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
5ddb | MENIN (Homosapiens) | 5 / 12 | TYR A 222SER A 178THR A 210THR A 193ALA A 194 | NoneNoneNoneDMS A 612 ( 4.7A)None | 1.47A | 4u15A-5ddbA:undetectable | 4u15A-5ddbA:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCH_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 8 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4uchA-3sxfA:undetectable4uchB-3sxfA:undetectable | 4uchA-3sxfA:20.004uchB-3sxfA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UGZ_A_H4BA760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4ugzA-3sxfA:undetectable4ugzB-3sxfA:undetectable | 4ugzA-3sxfA:20.774ugzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UGZ_B_H4BB760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 4ugzA-3sxfA:undetectable4ugzB-3sxfA:undetectable | 4ugzA-3sxfA:20.774ugzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH0_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 4uh0A-3sxfA:undetectable4uh0B-3sxfA:undetectable | 4uh0A-3sxfA:20.774uh0B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH2_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4uh2A-3sxfA:undetectable4uh2B-3sxfA:undetectable | 4uh2A-3sxfA:20.774uh2B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH2_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 4uh2A-3sxfA:undetectable4uh2B-3sxfA:undetectable | 4uh2A-3sxfA:20.774uh2B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4uh3A-3sxfA:undetectable4uh3B-3sxfA:undetectable | 4uh3A-3sxfA:20.774uh3B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 4uh4A-3sxfA:undetectable4uh4B-3sxfA:undetectable | 4uh4A-3sxfA:20.774uh4B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH5_A_H4BA760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4uh5A-3sxfA:undetectable4uh5B-3sxfA:undetectable | 4uh5A-3sxfA:19.814uh5B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 4uh6A-3sxfA:undetectable4uh6B-3sxfA:undetectable | 4uh6A-3sxfA:19.814uh6B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UPM_B_H4BB760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4upmA-3sxfA:undetectable4upmB-3sxfA:undetectable | 4upmA-3sxfA:20.774upmB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_A_0LIA1776_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | ALA A 119GLU A 136LEU A 215HIS A 223ALA A 540 | W4A A 716 ( 3.9A)DMS A 717 (-4.0A)NoneNoneDMS A 717 ( 4.5A) | 0.71A | 4v01A-5myvA:19.2 | 4v01A-5myvA:24.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_B_0LIB1770_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 5 / 12 | ALA A 119GLU A 136LEU A 215HIS A 223ALA A 540 | W4A A 716 ( 3.9A)DMS A 717 (-4.0A)NoneNoneDMS A 717 ( 4.5A) | 0.67A | 4v01B-5myvA:19.6 | 4v01B-5myvA:24.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 4v3uA-3sxfA:undetectable4v3uB-3sxfA:undetectable | 4v3uA-3sxfA:20.194v3uB-3sxfA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_D_H4BD760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 4v3uC-3sxfA:undetectable4v3uD-3sxfA:undetectable | 4v3uC-3sxfA:20.194v3uD-3sxfA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Y_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 4v3yA-3sxfA:undetectable4v3yB-3sxfA:undetectable | 4v3yA-3sxfA:20.774v3yB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUC_A_SAMA303_0 (CATECHOLO-METHYLTRANSFERASE) |
5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homosapiens) | 5 / 12 | VAL A 430GLU A 451GLY A 423ILE A 384HIS A 421 | None MN A 601 ( 2.5A)DMS A 607 ( 4.4A)NoneNone | 1.44A | 4xucA-5x49A:undetectable | 4xucA-5x49A:18.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUD_A_SAMA303_0 (CATECHOLO-METHYLTRANSFERASE) |
5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homosapiens) | 5 / 12 | VAL A 430GLU A 451GLY A 423ILE A 384HIS A 421 | None MN A 601 ( 2.5A)DMS A 607 ( 4.4A)NoneNone | 1.45A | 4xudA-5x49A:undetectable | 4xudA-5x49A:18.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | VAL A 374ALA A 388LYS A 390CYH A 441ASP A 502PHE A 503 | EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)EE4 A 701 (-4.6A)DMS A 702 ( 3.1A)None | 0.85A | 4xv2A-6c0tA:17.6 | 4xv2A-6c0tA:15.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Y03_A_SALA801_1 (PROTEIN POLYBROMO-1) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 4 / 7 | TYR A 97MET A 132ASN A 140ILE A 146 | NoneNoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.51A | 4y03A-4uydA:14.4 | 4y03A-4uydA:27.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z69_A_DIFA1007_1 (SERUM ALBUMIN) |
5hmp | UNCONVENTIONALMYOSIN-VC (Homosapiens) | 5 / 9 | ARG A 398LEU A 401LEU A 364ILE A 577SER A 366 | DMS A 805 (-3.4A)NoneNoneNoneNone | 1.24A | 4z69A-5hmpA:2.6 | 4z69A-5hmpA:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD4_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.50A | 5ad4A-3sxfA:undetectable5ad4B-3sxfA:undetectable | 5ad4A-3sxfA:20.775ad4B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD4_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5ad4A-3sxfA:undetectable5ad4B-3sxfA:undetectable | 5ad4A-3sxfA:20.775ad4B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD5_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.43A | 5ad5A-3sxfA:undetectable5ad5B-3sxfA:undetectable | 5ad5A-3sxfA:20.775ad5B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD5_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5ad5A-3sxfA:undetectable5ad5B-3sxfA:undetectable | 5ad5A-3sxfA:20.775ad5B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD7_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5ad7A-3sxfA:0.05ad7B-3sxfA:0.0 | 5ad7A-3sxfA:20.775ad7B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD8_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5ad8A-3sxfA:0.05ad8B-3sxfA:0.0 | 5ad8A-3sxfA:20.775ad8B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AD8_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5ad8A-3sxfA:undetectable5ad8B-3sxfA:undetectable | 5ad8A-3sxfA:20.775ad8B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADA_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5adaA-3sxfA:undetectable5adaB-3sxfA:undetectable | 5adaA-3sxfA:20.775adaB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADA_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5adaA-3sxfA:undetectable5adaB-3sxfA:undetectable | 5adaA-3sxfA:20.775adaB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADB_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.41A | 5adbA-3sxfA:undetectable5adbB-3sxfA:undetectable | 5adbA-3sxfA:20.775adbB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADC_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5adcA-3sxfA:undetectable5adcB-3sxfA:undetectable | 5adcA-3sxfA:20.775adcB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADC_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5adcA-3sxfA:undetectable5adcB-3sxfA:undetectable | 5adcA-3sxfA:20.775adcB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADD_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5addA-3sxfA:undetectable5addB-3sxfA:undetectable | 5addA-3sxfA:20.655addB-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADF_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5adfA-3sxfA:undetectable5adfB-3sxfA:undetectable | 5adfA-3sxfA:19.815adfB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADF_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5adfA-3sxfA:0.05adfB-3sxfA:0.9 | 5adfA-3sxfA:19.815adfB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADG_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.43A | 5adgA-3sxfA:undetectable5adgB-3sxfA:undetectable | 5adgA-3sxfA:19.815adgB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADG_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5adgA-3sxfA:undetectable5adgB-3sxfA:undetectable | 5adgA-3sxfA:19.815adgB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADI_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5adiA-3sxfA:undetectable5adiB-3sxfA:undetectable | 5adiA-3sxfA:19.815adiB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGK_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5agkA-3sxfA:undetectable5agkB-3sxfA:undetectable | 5agkA-3sxfA:20.775agkB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGL_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5aglA-3sxfA:undetectable5aglB-3sxfA:undetectable | 5aglA-3sxfA:20.775aglB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5agnA-3sxfA:undetectable5agnB-3sxfA:undetectable | 5agnA-3sxfA:20.775agnB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5agoA-3sxfA:undetectable5agoB-3sxfA:undetectable | 5agoA-3sxfA:20.775agoB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGO_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5agoA-3sxfA:undetectable5agoB-3sxfA:undetectable | 5agoA-3sxfA:20.775agoB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5agpA-3sxfA:undetectable5agpB-3sxfA:undetectable | 5agpA-3sxfA:20.775agpB-3sxfA:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.79A | 5b8iC-4lawA:18.3 | 5b8iC-4lawA:30.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.90A | 5b8iC-4lawA:18.3 | 5b8iC-4lawA:30.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 5 / 12 | VAL A 374ALA A 388LYS A 390CYH A 441PHE A 503 | EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)EE4 A 701 (-4.6A)None | 0.73A | 5cswA-6c0tA:17.4 | 5cswA-6c0tA:14.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.62A | 5d75A-4lawA:19.2 | 5d75A-4lawA:27.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.58A | 5d75A-4lawA:19.2 | 5d75A-4lawA:27.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ESF_A_TPFA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
3d7r | ESTERASE (Staphylococcusaureus) | 4 / 8 | ILE A 281TYR A 282GLY A 152LEU A 203 | DMS A1407 (-4.9A)DMS A1407 ( 4.2A)NoneNone | 0.92A | 5esfA-3d7rA:undetectable | 5esfA-3d7rA:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5fvpA-3sxfA:undetectable5fvpB-3sxfA:undetectable | 5fvpA-3sxfA:20.775fvpB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVQ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5fvqA-3sxfA:undetectable5fvqB-3sxfA:undetectable | 5fvqA-3sxfA:20.775fvqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVR_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5fvrA-3sxfA:undetectable5fvrB-3sxfA:undetectable | 5fvrA-3sxfA:20.775fvrB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVR_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5fvrA-3sxfA:undetectable5fvrB-3sxfA:undetectable | 5fvrA-3sxfA:20.775fvrB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVS_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5fvsA-3sxfA:undetectable5fvsB-3sxfA:undetectable | 5fvsA-3sxfA:20.775fvsB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5fvtA-3sxfA:undetectable5fvtB-3sxfA:undetectable | 5fvtA-3sxfA:20.775fvtB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5fvuA-3sxfA:undetectable5fvuB-3sxfA:undetectable | 5fvuA-3sxfA:19.815fvuB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVW_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5fvwA-3sxfA:undetectable5fvwB-3sxfA:undetectable | 5fvwA-3sxfA:19.815fvwB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVX_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5fvxA-3sxfA:0.05fvxB-3sxfA:0.5 | 5fvxA-3sxfA:19.815fvxB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FW0_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5fw0A-3sxfA:undetectable5fw0B-3sxfA:undetectable | 5fw0A-3sxfA:20.775fw0B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5g0nA-3sxfA:undetectable5g0nB-3sxfA:undetectable | 5g0nA-3sxfA:20.655g0nB-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5g0nA-3sxfA:undetectable5g0nB-3sxfA:undetectable | 5g0nA-3sxfA:20.655g0nB-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0O_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5g0oA-3sxfA:undetectable5g0oB-3sxfA:undetectable | 5g0oA-3sxfA:20.655g0oB-3sxfA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0O_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5g0oA-3sxfA:undetectable5g0oB-3sxfA:undetectable | 5g0oA-3sxfA:20.655g0oB-3sxfA:20.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.66A | 5gpgA-4lawA:20.0 | 5gpgA-4lawA:33.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.49A | 5gpgA-4lawA:20.0 | 5gpgA-4lawA:33.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 12 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 (-4.3A) | 0.53A | 5hkgA-4lawA:19.1 | 5hkgA-4lawA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 12 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneNoneDMS A 304 (-4.3A) | 0.57A | 5hkgA-4lawA:19.1 | 5hkgA-4lawA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.72A | 5huaA-4lawA:21.0 | 5huaA-4lawA:25.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.80A | 5huaA-4lawA:21.0 | 5huaA-4lawA:25.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNone | 0.92A | 5hw8A-4lawA:17.75hw8D-4lawA:18.0 | 5hw8A-4lawA:27.185hw8D-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNone | 0.74A | 5hw8A-4lawA:17.75hw8D-4lawA:18.0 | 5hw8A-4lawA:27.185hw8D-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.92A | 5hw8B-4lawA:17.7 | 5hw8B-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 1.12A | 5hw8B-4lawA:17.7 | 5hw8B-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.69A | 5hw8B-4lawA:17.7 | 5hw8B-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113LEU A 128PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.83A | 5hw8C-4lawA:17.65hw8H-4lawA:14.8 | 5hw8C-4lawA:27.185hw8H-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 10 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90LEU A 128PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.84A | 5hw8C-4lawA:17.65hw8H-4lawA:14.8 | 5hw8C-4lawA:27.185hw8H-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.70A | 5hw8D-4lawA:18.0 | 5hw8D-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.77A | 5hw8D-4lawA:18.0 | 5hw8D-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 1.07A | 5hw8D-4lawA:18.0 | 5hw8D-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.82A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.96A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.66A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 1.13A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNone | 1.42A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.56A | 5hw8E-4lawA:18.1 | 5hw8E-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 12 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.61A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 5 / 12 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | NoneNoneNoneDMS A 304 (-3.5A)None | 1.12A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 12 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.44A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 6 / 12 | TYR A 57PHE A 77VAL A 86ILE A 87TYR A 113ILE A 122 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)NoneNone | 1.43A | 5hw8B-4lawA:17.75hw8F-4lawA:14.95hw8G-4lawA:17.3 | 5hw8B-4lawA:27.185hw8F-4lawA:27.185hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.71A | 5hw8G-4lawA:17.3 | 5hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNone | 1.36A | 5hw8G-4lawA:17.3 | 5hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 8 / 11 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.59A | 5hw8G-4lawA:17.3 | 5hw8G-4lawA:27.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HW8_H_FK5H201_1 (FK506-BINDINGPROTEIN 1) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 7 / 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.69A | 5hw8H-4lawA:14.8 | 5hw8H-4lawA:27.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.84A | 5hwcA-4lawA:19.1 | 5hwcA-4lawA:31.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 11 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.59A | 5hwcA-4lawA:19.1 | 5hwcA-4lawA:31.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 9 | ARG A 87SER A 90GLY A 92MET A 180GLU A 181 | SO4 A 500 (-2.9A)SO4 A 500 (-2.9A)DMS A 515 ( 4.1A)DMS A 513 ( 4.3A)SO4 A 500 ( 4.2A) | 0.57A | 5i3cA-4mchA:32.2 | 5i3cA-4mchA:25.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IZJ_G_AZ1G2_1 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA47P-AZ1-DAR-DAR) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 7 | GLY A 367GLY A 369PHE A 371VAL A 374LYS A 390LEU A 392 | EE4 A 701 (-3.9A)EE4 A 701 (-3.4A)EE4 A 701 (-3.0A)EE4 A 701 (-4.4A)DMS A 702 (-3.5A)EE4 A 701 ( 4.6A) | 0.51A | 5izjA-6c0tA:31.6 | 5izjA-6c0tA:18.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5J5X_B_AZ1B2_1 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA47P-AZ1-DAL-DAR-DAR-DAR-DAR) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 4 / 7 | GLY A 367GLY A 369VAL A 374LYS A 390 | EE4 A 701 (-3.9A)EE4 A 701 (-3.4A)EE4 A 701 (-4.4A)DMS A 702 (-3.5A) | 0.29A | 5j5xA-6c0tA:41.6 | 5j5xA-6c0tA:18.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JH7_D_6K9D502_0 (TUBULIN BETA-2BCHAIN) |
5nh0 | REPLICASEPOLYPROTEIN 1AB (HumancoronavirusNL63) | 5 / 11 | GLN A 267ASN A 231VAL A 204SER A 201ASP A 202 | NoneNoneNoneNoneDMS A 302 (-3.8A) | 1.47A | 5jh7D-5nh0A:undetectable | 5jh7D-5nh0A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KB5_A_ADNA401_2 (ADENOSINE KINASE) |
2vuw | SERINE/THREONINE-PROTEIN KINASE HASPIN (Homosapiens) | 4 / 4 | ASN A 741LEU A 745SER A 786LEU A 791 | NoneNoneNoneDMS A1802 ( 4.6A) | 1.36A | 5kb5A-2vuwA:undetectable | 5kb5A-2vuwA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KQX_A_ROCA101_1 (PROTEASE E35D-SQV) |
4g09 | HISTIDINOLDEHYDROGENASE (Brucellasuis) | 6 / 12 | ALA A 243ASP A 244GLY A 352ILE A 351VAL A 239ILE A 241 | NoneNoneNoneNoneDMS A 504 ( 4.7A)None | 1.46A | 5kqxA-4g09A:undetectable | 5kqxA-4g09A:12.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L2I_A_LQQA900_1 (CYCLIN-DEPENDENTKINASE 6) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | GLY A 99VAL A 106ALA A 119VAL A 157PHE A 177LEU A 232 | W4A A 716 ( 4.0A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 (-4.3A)DMS A 717 ( 3.9A)None | 0.74A | 5l2iA-5myvA:14.6 | 5l2iA-5myvA:26.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENTKINASE 6) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | GLY A 99VAL A 106ALA A 119VAL A 157PHE A 177LEU A 232 | W4A A 716 ( 4.0A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 (-4.3A)DMS A 717 ( 3.9A)None | 0.94A | 5l2tA-5myvA:14.5 | 5l2tA-5myvA:26.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L8D_A_EDTA609_0 (NICKEL-BINDINGPERIPLASMIC PROTEIN) |
5kta | FDHC (Acinetobacternosocomialis) | 4 / 8 | TRP A 50ARG A 28TYR A 65THR A 79 | DMS A 204 (-3.4A)SO4 A 202 (-3.1A)DMS A 204 (-4.5A)None | 1.26A | 5l8dA-5ktaA:0.3 | 5l8dA-5ktaA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LSA_A_SAMA303_0 (CATECHOLO-METHYLTRANSFERASE) |
5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homosapiens) | 5 / 12 | VAL A 430GLU A 451GLY A 423ILE A 384HIS A 421 | None MN A 601 ( 2.5A)DMS A 607 ( 4.4A)NoneNone | 1.40A | 5lsaA-5x49A:undetectable | 5lsaA-5x49A:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MO4_A_NILA601_1 (TYROSINE-PROTEINKINASE ABL1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 5 / 10 | LEU A 366VAL A 374LYS A 390GLU A 409GLY A 444 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)None | 0.57A | 5mo4A-6c0tA:16.5 | 5mo4A-6c0tA:11.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MVM_E_PFLE409_1 (PROTON-GATED IONCHANNEL) |
5nfh | METHIONYL-TRNASYNTHETASE, PUTATIVE (Trypanosomabrucei) | 5 / 10 | ILE A 437ALA A 439ALA A 524ILE A 525ILE A 542 | NoneDMS A 805 ( 4.2A)NoneNoneNone | 0.95A | 5mvmD-5nfhA:5.55mvmE-5nfhA:5.5 | 5mvmD-5nfhA:9.305mvmE-5nfhA:9.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWU_A_EDTA609_0 (NICKEL-BINDINGPERIPLASMIC PROTEIN) |
5kta | FDHC (Acinetobacternosocomialis) | 4 / 8 | TRP A 50ARG A 28TYR A 65THR A 79 | DMS A 204 (-3.4A)SO4 A 202 (-3.1A)DMS A 204 (-4.5A)None | 1.26A | 5mwuA-5ktaA:0.3 | 5mwuA-5ktaA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OWR_A_1N1A401_1 (SERINE/THREONINE-PROTEIN KINASE 10) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 4 / 8 | ALA A 388GLU A 409CYH A 441ASP A 502 | EE4 A 701 (-3.3A)DMS A 702 ( 4.2A)EE4 A 701 (-4.6A)DMS A 702 ( 3.1A) | 0.63A | 5owrA-6c0tA:15.6 | 5owrA-6c0tA:15.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5PBE_A_TYLA2001_1 (BROMODOMAIN ADJACENTTO ZINC FINGERDOMAIN PROTEIN 2B) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 4 / 6 | PRO A 82VAL A 87TYR A 97ILE A 146 | V1T A1171 (-4.2A)V1T A1171 (-4.9A)NoneDMS A1169 ( 4.3A) | 0.77A | 5pbeA-4uydA:15.5 | 5pbeA-4uydA:34.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5PBE_A_TYLA2001_1 (BROMODOMAIN ADJACENTTO ZINC FINGERDOMAIN PROTEIN 2B) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 4 / 6 | VAL A 87TYR A 97ASN A 140ILE A 146 | V1T A1171 (-4.9A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.36A | 5pbeA-4uydA:15.5 | 5pbeA-4uydA:34.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T2Z_B_017B201_1 (PROTEASE) |
4mch | URIDINEPHOSPHORYLASE (Aliivibriofischeri) | 5 / 12 | LEU A 176GLY A 92ALA A 91GLY A 101ILE A 104 | NoneDMS A 515 ( 4.1A)NoneNoneNone | 1.09A | 5t2zA-4mchA:undetectable | 5t2zA-4mchA:19.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE0_A_XINA401_1 (AP2-ASSOCIATEDPROTEIN KINASE 1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | LEU A 376ALA A 388GLU A 409MET A 413VAL A 422GLY A 444 | NoneEE4 A 701 (-3.3A)DMS A 702 ( 4.2A)NoneNoneNone | 0.71A | 5te0A-6c0tA:16.3 | 5te0A-6c0tA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNR_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5unrA-3sxfA:undetectable5unrB-3sxfA:undetectable | 5unrA-3sxfA:20.775unrB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNS_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5unsA-3sxfA:undetectable5unsB-3sxfA:undetectable | 5unsA-3sxfA:20.775unsB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNS_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5unsA-3sxfA:undetectable5unsB-3sxfA:undetectable | 5unsA-3sxfA:20.775unsB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.49A | 5untA-3sxfA:undetectable5untB-3sxfA:undetectable | 5untA-3sxfA:20.775untB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5untA-3sxfA:undetectable5untB-3sxfA:undetectable | 5untA-3sxfA:20.775untB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5unuA-3sxfA:undetectable5unuB-3sxfA:undetectable | 5unuA-3sxfA:20.775unuB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNU_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.41A | 5unuA-3sxfA:undetectable5unuB-3sxfA:undetectable | 5unuA-3sxfA:20.775unuB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNV_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.48A | 5unvA-3sxfA:undetectable5unvB-3sxfA:undetectable | 5unvA-3sxfA:20.775unvB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.41A | 5unwA-3sxfA:undetectable5unwB-3sxfA:undetectable | 5unwA-3sxfA:20.775unwB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.40A | 5unxA-3sxfA:undetectable5unxB-3sxfA:undetectable | 5unxA-3sxfA:20.775unxB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNY_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5unyA-3sxfA:undetectable5unyB-3sxfA:undetectable | 5unyA-3sxfA:20.775unyB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 5 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5unzA-3sxfA:0.05unzB-3sxfA:0.0 | 5unzA-3sxfA:20.775unzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 5unzA-3sxfA:undetectable5unzB-3sxfA:undetectable | 5unzA-3sxfA:20.775unzB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO0_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5uo0A-3sxfA:2.65uo0B-3sxfA:undetectable | 5uo0A-3sxfA:20.775uo0B-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO1_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5uo1A-3sxfA:undetectable5uo1B-3sxfA:undetectable | 5uo1A-3sxfA:19.815uo1B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO1_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5uo1A-3sxfA:undetectable5uo1B-3sxfA:undetectable | 5uo1A-3sxfA:19.815uo1B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5uo2A-3sxfA:undetectable5uo2B-3sxfA:undetectable | 5uo2A-3sxfA:19.815uo2B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO3_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5uo3A-3sxfA:undetectable5uo3B-3sxfA:undetectable | 5uo3A-3sxfA:19.815uo3B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO4_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.43A | 5uo4A-3sxfA:undetectable5uo4B-3sxfA:undetectable | 5uo4A-3sxfA:19.815uo4B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO4_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5uo4A-3sxfA:undetectable5uo4B-3sxfA:undetectable | 5uo4A-3sxfA:19.815uo4B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO5_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5uo5A-3sxfA:undetectable5uo5B-3sxfA:undetectable | 5uo5A-3sxfA:19.815uo5B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCV_A_1N1A404_2 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
5x49 | PROBABLE XAA-PROAMINOPEPTIDASE 3 (Homosapiens) | 4 / 5 | VAL A 303HIS A 431LEU A 313ASP A 342 | None01B A 604 (-4.0A)DMS A 605 (-4.2A) MN A 602 (-2.6A) | 1.29A | 5vcvA-5x49A:undetectable | 5vcvA-5x49A:22.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 6 / 12 | LEU A 366VAL A 374ALA A 388LYS A 390GLU A 409CYH A 441 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)EE4 A 701 (-4.6A) | 0.47A | 5vcyA-6c0tA:24.3 | 5vcyA-6c0tA:13.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VEU_B_RITB602_1 (CYTOCHROME P450 3A5) |
5ddb | MENIN (Homosapiens) | 5 / 12 | PHE A 146PHE A 93ALA A 242ILE A 243GLY A 42 | NoneNoneDMS A 607 ( 3.8A)NoneNone | 0.95A | 5veuB-5ddbA:undetectable | 5veuB-5ddbA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_A_PCFA1805_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) |
3lcr | TAUTOMYCETINBIOSYNTHETIC PKS (Streptomycessp.CK4412) | 4 / 7 | VAL A 67HIS A 131ILE A 259THR A 69 | FMT A3613 (-4.6A)NoneNoneDMS A3092 (-3.8A) | 1.06A | 5vkqA-3lcrA:undetectable5vkqD-3lcrA:undetectable | 5vkqA-3lcrA:11.035vkqD-3lcrA:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUJ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.50A | 5vujA-3sxfA:undetectable5vujB-3sxfA:undetectable | 5vujA-3sxfA:20.775vujB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUK_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.49A | 5vukA-3sxfA:undetectable5vukB-3sxfA:undetectable | 5vukA-3sxfA:20.775vukB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUK_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5vukA-3sxfA:undetectable5vukB-3sxfA:undetectable | 5vukA-3sxfA:20.775vukB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUL_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5vulA-3sxfA:undetectable5vulB-3sxfA:undetectable | 5vulA-3sxfA:20.775vulB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUL_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5vulA-3sxfA:undetectable5vulB-3sxfA:undetectable | 5vulA-3sxfA:20.775vulB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUM_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.49A | 5vumA-3sxfA:undetectable5vumB-3sxfA:undetectable | 5vumA-3sxfA:20.775vumB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUM_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5vumA-3sxfA:undetectable5vumB-3sxfA:undetectable | 5vumA-3sxfA:20.775vumB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vunA-3sxfA:undetectable5vunB-3sxfA:undetectable | 5vunA-3sxfA:20.775vunB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5vunA-3sxfA:undetectable5vunB-3sxfA:undetectable | 5vunA-3sxfA:20.775vunB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUO_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5vuoA-3sxfA:undetectable5vuoB-3sxfA:undetectable | 5vuoA-3sxfA:20.775vuoB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUO_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5vuoA-3sxfA:undetectable5vuoB-3sxfA:undetectable | 5vuoA-3sxfA:20.775vuoB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUP_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5vupA-3sxfA:undetectable5vupB-3sxfA:undetectable | 5vupA-3sxfA:20.775vupB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUP_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5vupA-3sxfA:undetectable5vupB-3sxfA:undetectable | 5vupA-3sxfA:20.775vupB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUQ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vuqA-3sxfA:undetectable5vuqB-3sxfA:undetectable | 5vuqA-3sxfA:20.775vuqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUQ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5vuqA-3sxfA:undetectable5vuqB-3sxfA:undetectable | 5vuqA-3sxfA:20.775vuqB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUR_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5vurA-3sxfA:undetectable5vurB-3sxfA:undetectable | 5vurA-3sxfA:20.775vurB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUS_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5vusA-3sxfA:undetectable5vusB-3sxfA:undetectable | 5vusA-3sxfA:20.775vusB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUS_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5vusA-3sxfA:undetectable5vusB-3sxfA:undetectable | 5vusA-3sxfA:20.775vusB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 5vutA-3sxfA:undetectable5vutB-3sxfA:undetectable | 5vutA-3sxfA:20.775vutB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5vutA-3sxfA:undetectable5vutB-3sxfA:undetectable | 5vutA-3sxfA:20.775vutB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.47A | 5vuuA-3sxfA:undetectable5vuuB-3sxfA:undetectable | 5vuuA-3sxfA:20.775vuuB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUU_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5vuuA-3sxfA:undetectable5vuuB-3sxfA:undetectable | 5vuuA-3sxfA:20.775vuuB-3sxfA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUV_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.42A | 5vuvA-3sxfA:undetectable5vuvB-3sxfA:undetectable | 5vuvA-3sxfA:19.815vuvB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUV_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5vuvA-3sxfA:undetectable5vuvB-3sxfA:undetectable | 5vuvA-3sxfA:19.815vuvB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUW_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5vuwA-3sxfA:undetectable5vuwB-3sxfA:undetectable | 5vuwA-3sxfA:19.815vuwB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 5vuwA-3sxfA:undetectable5vuwB-3sxfA:undetectable | 5vuwA-3sxfA:19.815vuwB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5vuxA-3sxfA:undetectable5vuxB-3sxfA:undetectable | 5vuxA-3sxfA:19.815vuxB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 5vuxA-3sxfA:0.05vuxB-3sxfA:0.0 | 5vuxA-3sxfA:19.815vuxB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUY_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.38A | 5vuyA-3sxfA:undetectable5vuyB-3sxfA:undetectable | 5vuyA-3sxfA:19.815vuyB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vuzA-3sxfA:undetectable5vuzB-3sxfA:undetectable | 5vuzA-3sxfA:19.815vuzB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUZ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5vuzA-3sxfA:undetectable5vuzB-3sxfA:undetectable | 5vuzA-3sxfA:19.815vuzB-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV0_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vv0A-3sxfA:undetectable5vv0B-3sxfA:1.0 | 5vv0A-3sxfA:19.815vv0B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV0_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.45A | 5vv0A-3sxfA:undetectable5vv0B-3sxfA:1.0 | 5vv0A-3sxfA:19.815vv0B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV1_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 5vv1A-3sxfA:undetectable5vv1B-3sxfA:undetectable | 5vv1A-3sxfA:19.815vv1B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV1_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 5vv1A-3sxfA:undetectable5vv1B-3sxfA:undetectable | 5vv1A-3sxfA:19.815vv1B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vv2A-3sxfA:undetectable5vv2B-3sxfA:undetectable | 5vv2A-3sxfA:19.815vv2B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV2_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.46A | 5vv2A-3sxfA:undetectable5vv2B-3sxfA:undetectable | 5vv2A-3sxfA:19.815vv2B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV3_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 5vv3A-3sxfA:undetectable5vv3B-3sxfA:undetectable | 5vv3A-3sxfA:19.815vv3B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV4_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 6 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 5vv4A-3sxfA:0.05vv4B-3sxfA:0.9 | 5vv4A-3sxfA:19.815vv4B-3sxfA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5W7P_A_SAMA501_0 (OXAC) |
5nh0 | REPLICASEPOLYPROTEIN 1AB (HumancoronavirusNL63) | 5 / 12 | PHE A 185GLU A 194GLY A 170SER A 169ARG A 130 | NoneNoneNoneNoneDMS A 303 (-3.5A) | 1.15A | 5w7pA-5nh0A:undetectable | 5w7pA-5nh0A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WK9_A_CAMA503_0 (CAMPHOR5-MONOOXYGENASE) |
5aih | LIMONENE-1,2-EPOXIDEHYDROLASE (unidentified) | 4 / 7 | TYR A 32LEU A 50VAL A 96ASP A 112 | NoneDMS A 203 (-4.7A)NoneDMS A 201 ( 4.8A) | 1.05A | 5wk9A-5aihA:undetectable | 5wk9A-5aihA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WQP_A_NCAA302_0 (PROBABLEDEHYDROGENASE) |
3p1v | METALLO-ENDOPEPTIDASE (Bacteroidesovatus) | 4 / 8 | SER A 90GLN A 74TYR A 292MET A 419 | NoneDMS A 437 ( 3.9A)NoneNone | 1.36A | 5wqpA-3p1vA:undetectable | 5wqpA-3p1vA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_A_SAMA501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
5zzn | - (-) | 5 / 12 | ALA U 53PRO U 54ASP U 60LEU U 67LEU U 75 | DMS U 202 ( 3.5A)HTG U 203 (-3.9A)HTG U 203 (-4.3A)NoneNone | 1.04A | 5wwsA-5zznU:undetectable | 5wwsA-5zznU:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X6Y_C_SAMC901_0 (MRNA CAPPING ENZYMEP5) |
5ihr | PROBABLEBETA-GALACTOSIDASE A (Aspergillusniger) | 5 / 11 | VAL A 155GLY A 157SER A 162ALA A 169LEU A 152 | DMS A3008 (-4.1A)NoneNoneDMS A3008 ( 4.1A)None | 1.19A | 5x6yC-5ihrA:undetectable | 5x6yC-5ihrA:23.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XV7_A_EMHA705_1 (SERINE-ARGININE (SR)PROTEIN KINASE 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 10 / 12 | ARG A 96LEU A 98GLY A 99VAL A 106ALA A 119PHE A 177GLY A 181VAL A 235TYR A 239ALA A 540 | NoneW4A A 716 (-4.1A)W4A A 716 ( 4.0A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 ( 3.9A)W4A A 716 (-3.8A)W4A A 716 ( 4.9A)W4A A 716 (-4.8A)DMS A 717 ( 4.5A) | 0.46A | 5xv7A-5myvA:49.0 | 5xv7A-5myvA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XV7_A_EMHA705_1 (SERINE-ARGININE (SR)PROTEIN KINASE 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | ARG A 96PHE A 177GLY A 181HIS A 182VAL A 235TYR A 239ALA A 540 | NoneDMS A 717 ( 3.9A)W4A A 716 (-3.8A)W4A A 716 ( 3.6A)W4A A 716 ( 4.9A)W4A A 716 (-4.8A)DMS A 717 ( 4.5A) | 0.80A | 5xv7A-5myvA:49.0 | 5xv7A-5myvA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XV7_A_EMHA705_1 (SERINE-ARGININE (SR)PROTEIN KINASE 1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 6 / 12 | LEU A 98GLY A 99VAL A 106ALA A 119PHE A 177VAL A 240 | W4A A 716 (-4.1A)W4A A 716 ( 4.0A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)DMS A 717 ( 3.9A)None | 1.22A | 5xv7A-5myvA:49.0 | 5xv7A-5myvA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Y1Y_A_HNQA201_1 (BROMODOMAIN-CONTAINING PROTEIN 4) |
4uyd | BROMODOMAIN-CONTAINING PROTEIN 4 (Homosapiens) | 8 / 8 | PRO A 82VAL A 87LEU A 92LEU A 94CYH A 136TYR A 139ASN A 140ILE A 146 | V1T A1171 (-4.2A)V1T A1171 (-4.9A)V1T A1171 (-3.8A)NoneV1T A1171 ( 4.4A)NoneV1T A1171 (-3.1A)DMS A1169 ( 4.3A) | 0.28A | 5y1yA-4uydA:24.2 | 5y1yA-4uydA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | LEU A 98VAL A 106ALA A 119LYS A 121GLU A 136GLY A 181LEU A 232 | W4A A 716 (-4.1A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)W4A A 716 (-3.8A)None | 1.05A | 5y7zA-5myvA:23.9 | 5y7zA-5myvA:11.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | LEU A 98VAL A 106ALA A 119LYS A 121GLU A 136GLY A 181LEU A 232 | W4A A 716 (-4.1A)W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)W4A A 716 (-3.8A)None | 1.05A | 5y7zA-5myvA:23.9 | 5y7zA-5myvA:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 8 / 12 | LEU A 366VAL A 374ALA A 388LYS A 390GLU A 409CYH A 441GLY A 444ASP A 502 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)EE4 A 701 (-4.6A)NoneDMS A 702 ( 3.1A) | 0.85A | 5y80A-6c0tA:24.9 | 5y80A-6c0tA:26.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_C_CUC605_0 (TYROSINASE) |
4xct | MATRIXMETALLOPROTEINASE-9,MATRIXMETALLOPROTEINASE-9 (Homosapiens) | 4 / 5 | HIS A 190HIS A 175HIS A 203PHE A 192 | ZN A 303 ( 3.2A) ZN A 303 (-3.1A) ZN A 303 (-3.1A)DMS A 307 (-4.2A) | 1.28A | 5zrdC-4xctA:undetectable | 5zrdC-4xctA:12.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUQ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6auqA-3sxfA:undetectable6auqB-3sxfA:undetectable | 6auqA-3sxfA:9.136auqB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUR_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 6aurA-3sxfA:undetectable6aurB-3sxfA:undetectable | 6aurA-3sxfA:9.136aurB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUR_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 6aurA-3sxfA:undetectable6aurB-3sxfA:undetectable | 6aurA-3sxfA:9.136aurB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUS_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 6ausA-3sxfA:undetectable6ausB-3sxfA:undetectable | 6ausA-3sxfA:9.136ausB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUS_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 6ausA-3sxfA:undetectable6ausB-3sxfA:undetectable | 6ausA-3sxfA:9.136ausB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6autA-3sxfA:undetectable6autB-3sxfA:undetectable | 6autA-3sxfA:9.136autB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 6auuA-3sxfA:undetectable6auuB-3sxfA:undetectable | 6auuA-3sxfA:9.136auuB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUU_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6auuA-3sxfA:undetectable6auuB-3sxfA:undetectable | 6auuA-3sxfA:9.136auuB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUV_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6auvA-3sxfA:undetectable6auvB-3sxfA:undetectable | 6auvA-3sxfA:9.136auvB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUW_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.48A | 6auwA-3sxfA:undetectable6auwB-3sxfA:undetectable | 6auwA-3sxfA:9.136auwB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6auwA-3sxfA:undetectable6auwB-3sxfA:undetectable | 6auwA-3sxfA:9.136auwB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 6auxA-3sxfA:undetectable6auxB-3sxfA:undetectable | 6auxA-3sxfA:9.136auxB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 6auxA-3sxfA:undetectable6auxB-3sxfA:undetectable | 6auxA-3sxfA:9.136auxB-3sxfA:9.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUY_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 6auyA-3sxfA:undetectable6auyB-3sxfA:undetectable | 6auyA-3sxfA:10.196auyB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 6auzA-3sxfA:undetectable6auzB-3sxfA:undetectable | 6auzA-3sxfA:10.196auzB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV0_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.46A | 6av0A-3sxfA:undetectable6av0B-3sxfA:undetectable | 6av0A-3sxfA:10.196av0B-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV1_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.42A | 6av1A-3sxfA:undetectable6av1B-3sxfA:undetectable | 6av1A-3sxfA:10.196av1B-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV4_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 6av4A-3sxfA:undetectable6av4B-3sxfA:undetectable | 6av4A-3sxfA:10.196av4B-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV5_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 6av5A-3sxfA:undetectable6av5B-3sxfA:undetectable | 6av5A-3sxfA:10.196av5B-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BSG_A_EFZA601_1 (REVERSETRANSCRIPTASE P66SUBUNIT) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 10 | LEU A 8VAL A 14VAL A 311GLY A 307LEU A 11 | NoneACT A 503 ( 4.9A)NoneNoneDMS A 511 (-4.8A) | 1.50A | 6bsgA-4pg6A:undetectable | 6bsgA-4pg6A:11.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BSJ_A_EFZA601_1 (REVERSETRANSCRIPTASE P66SUBUNIT) |
4pg6 | HOMOSERINEDEHYDROGENASE (Staphylococcusaureus) | 5 / 10 | LEU A 8VAL A 14VAL A 311GLY A 307LEU A 11 | NoneACT A 503 ( 4.9A)NoneNoneDMS A 511 (-4.8A) | 1.48A | 6bsjA-4pg6A:undetectable | 6bsjA-4pg6A:11.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CE2_B_SVRB202_2 (-) |
3d7r | ESTERASE (Staphylococcusaureus) | 5 / 12 | LEU A 99LEU A 98GLY A 150GLY A 85PRO A 93 | NoneDMS A1417 (-3.9A)NoneNoneDMS A1410 (-4.7A) | 1.07A | 6ce2B-3d7rA:undetectable | 6ce2B-3d7rA:15.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CHG_C_SAMC1101_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-4 SPECIFIC) |
5w4m | TRANSCRIPTIONALREGULATOR (Streptococcusdysgalactiae) | 5 / 12 | ILE A 211ASN A 190TYR A 266HIS A 231LEU A 207 | NoneNoneDMS A 305 (-3.6A)NoneNone | 1.18A | 6chgC-5w4mA:undetectable | 6chgC-5w4mA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CIC_A_H4BA802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.45A | 6cicA-3sxfA:undetectable6cicB-3sxfA:undetectable | 6cicA-3sxfA:10.196cicB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CIC_B_H4BB802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.43A | 6cicA-3sxfA:undetectable6cicB-3sxfA:undetectable | 6cicA-3sxfA:10.196cicB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CID_A_H4BA802_0 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | ARG A 286VAL A 277TRP A 274PHE A 269 | DMS A 711 (-4.1A)NoneNoneDMS A 711 (-3.9A) | 1.44A | 6cidA-3sxfA:undetectable6cidB-3sxfA:1.0 | 6cidA-3sxfA:10.196cidB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CID_B_H4BB803_0 (NITRIC OXIDESYNTHASE, BRAIN) |
3sxf | CALMODULIN-DOMAINPROTEIN KINASE 1 (Toxoplasmagondii) | 4 / 7 | TRP A 274PHE A 269ARG A 286VAL A 277 | NoneDMS A 711 (-3.9A)DMS A 711 (-4.1A)None | 1.44A | 6cidA-3sxfA:undetectable6cidB-3sxfA:1.0 | 6cidA-3sxfA:10.196cidB-3sxfA:10.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DWD_B_GLYB709_0 (DEOXYNUCLEOSIDETRIPHOSPHATETRIPHOSPHOHYDROLASESAMHD1) |
5aih | LIMONENE-1,2-EPOXIDEHYDROLASE (unidentified) | 4 / 5 | GLY A 21ASP A 20ARG A 43ARG A 47 | NoneEDO A 304 ( 2.8A)DMS A 202 (-3.8A)EDO A 304 (-4.5A) | 1.17A | 6dwdB-5aihA:undetectable6dwdD-5aihA:undetectable | 6dwdB-5aihA:13.416dwdD-5aihA:13.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6ESM_A_PZEA307_1 (MATRIXMETALLOPROTEINASE-9,MATRIXMETALLOPROTEINASE-9) |
4xct | MATRIXMETALLOPROTEINASE-9,MATRIXMETALLOPROTEINASE-9 (Homosapiens) | 3 / 3 | TYR A 179HIS A 190PHE A 192 | DMS A 307 ( 3.9A) ZN A 303 ( 3.2A)DMS A 307 (-4.2A) | 0.10A | 6esmA-4xctA:32.9 | 6esmA-4xctA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EU9_D_READ601_1 (RETINOIC ACIDRECEPTOR) |
3h0u | PUTATIVE ENOYL-COAHYDRATASE (Streptomycesavermitilis) | 4 / 7 | PHE A 264LEU A 274GLY A 120GLY A 36 | NoneNoneDMS A 1 (-3.3A)None | 0.78A | 6eu9D-3h0uA:undetectable | 6eu9D-3h0uA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD4_A_STIA604_0 (TYROSINE-PROTEINKINASE ABL1) |
5myv | SRSF PROTEIN KINASE2,SRSF PROTEINKINASE 2 (Homosapiens) | 7 / 12 | VAL A 106ALA A 119LYS A 121GLU A 136VAL A 157LEU A 232ALA A 540 | W4A A 716 ( 4.7A)W4A A 716 ( 3.9A)SO4 A 702 (-3.3A)DMS A 717 (-4.0A)DMS A 717 (-4.3A)NoneDMS A 717 ( 4.5A) | 0.99A | 6hd4A-5myvA:19.7 | 6hd4A-5myvA:11.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_B_STIB601_0 (TYROSINE-PROTEINKINASE ABL1) |
6c0t | CGMP-DEPENDENTPROTEIN KINASE 1 (Homosapiens) | 7 / 12 | LEU A 366VAL A 374ALA A 388LYS A 390GLU A 409MET A 413VAL A 422 | EE4 A 701 ( 4.6A)EE4 A 701 (-4.4A)EE4 A 701 (-3.3A)DMS A 702 (-3.5A)DMS A 702 ( 4.2A)NoneNone | 0.77A | 6hd6B-6c0tA:16.4 | 6hd6B-6c0tA:26.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6IBL_A_H98A501_0 (THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR) |
5ihr | PROBABLEBETA-GALACTOSIDASE A (Aspergillusniger) | 5 / 12 | THR A 625VAL A 627VAL A 599PHE A 621ASN A 642 | DMS A3001 (-3.8A)NoneNoneNoneNone | 1.45A | 6iblA-5ihrA:undetectable | 6iblA-5ihrA:17.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6IBL_B_H98B501_0 (THIOREDOXIN 1,BETA-1ADRENERGIC RECEPTOR) |
5ihr | PROBABLEBETA-GALACTOSIDASE A (Aspergillusniger) | 5 / 12 | THR A 625VAL A 627VAL A 599PHE A 621ASN A 642 | DMS A3001 (-3.8A)NoneNoneNoneNone | 1.47A | 6iblB-5ihrA:undetectable | 6iblB-5ihrA:17.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.72A | 6mkeA-4lawA:21.26mkeD-4lawA:21.2 | 6mkeA-4lawA:16.066mkeD-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.77A | 6mkeA-4lawA:21.26mkeD-4lawA:21.2 | 6mkeA-4lawA:16.066mkeD-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.76A | 6mkeB-4lawA:21.06mkeC-4lawA:20.9 | 6mkeB-4lawA:16.066mkeC-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 12 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.81A | 6mkeB-4lawA:21.06mkeC-4lawA:20.9 | 6mkeB-4lawA:16.066mkeC-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.74A | 6mkeC-4lawA:20.9 | 6mkeC-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.81A | 6mkeC-4lawA:20.9 | 6mkeC-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.74A | 6mkeD-4lawA:21.2 | 6mkeD-4lawA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homosapiens) | 9 / 10 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.80A | 6mkeD-4lawA:21.2 | 6mkeD-4lawA:16.06 |